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Abstract
Microbial biofilms are communities of microorganisms that exhibit co-operative behaviour,
producing a matrix of exopolysaccharide that enmeshes the community. The well-studied
human pathogens Escherichia coli and Salmonella enterica produce a biofilm matrix comprised
chiefly of the biopolymer cellulose, along with amyloid protein fibers termed curli. This biofilm
matrix confers surface adherence and acts as a protective barrier to disinfectants,
antimicrobials, environmental stressors, and host immune responses. Pertaining to this
research, the bcsEFG operon, conserved in the Enterobacteriaceae, encodes an inner
membrane-spanning complex responsible for the addition of a phosphoethanolamine (pEtN)
modification to microbial cellulose, essential for extracellular matrix assembly and biofilm
architecture. Furthermore, E. coli deficient in bcsG produce a biofilm matrix lacking structural
integrity and the self-assembling architecture observed in wild-type E. coli. The presence of a
pEtN-substituted cellulose matrix was shown to be important in bladder epithelial colonization
by uropathogenic E. coli, further suggesting its role as a virulence factor in etiological agents of
urinary tract infections observed in the clinic. The purpose of this research was to characterize
the EcBcsG enzyme, a putative pEtN transferase, by resolving its structure, understanding its
role in pEtN substitution of the cellulose matrix in E. coli, and by elucidating its catalytic
mechanism to enable future efforts in drug discovery. All these research objectives were
achieved, shedding light on the biochemical basis of pEtN cellulose in E. coli. The de novo X-ray
crystal structure of the C-terminal catalytic domain of EcBcsG was solved using the singlewavelength anomalous diffraction (SAD) technique phased on L-selenomethionine substituted
EcBcsG crystals and revealed EcBcsG folds as a zinc-dependent phosphotransferase belonging
to the pEtN transferase family. The EcBcsG active site was mapped using functional
complementation, revealing EcBcsG shares a partially conserved active site with other known
pEtN transferase family members, including enzymes responsible for resistance to cationic
antimicrobial peptides (CAMPs). Using mock cosubstrates para-nitrophenyl
phosphoethanolamine (p-NPPE) and cellooligosaccharides, the specific activity of EcBcsG was
measured to be 11.45 +/- 0.51 nmol min-1 mg-1 in the presence of the cellulo-pentasaccharide.
The kinetic parameters were measured as Km = 1.673 ± 0.382 mM, kcat = 6.876 x 10-3 ± 4.14 x 104 -1
s , and kcat/Km = 4.110 ± 0.970 M s-1. The enzymatic product of this reaction was identified
and confirmed in vitro. Finally, the covalent phospho-enzyme intermediate was isolated,
providing evidence for an EcBcsG catalytic mechanism. The structural and functional model of
the cellulose modifying complex, resulting from this work, provides new insight into the
biochemical basis for the biofilm matrix of E. coli and other Enterobacteriaceae. The research
presented here offers opportunities in structure-based drug discovery and other efforts in
inhibiting microbial biofilms and including the possibility of limiting the resilience of biofilmforming pathogens. Additionally, further understanding of bcsEFG-directed
phosphoethanolamine cellulose production may enable biosynthetic engineering of new
cellulosic materials or confer the advantages of phosphoethanolamine cellulose in new
organisms.
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1. Introduction
1.1 Microbial biofilms
Microbial biofilms are defined as communities of microorganisms that reside in a matrix
of extracellular polymeric substances (EPS), produced by the communities themselves, that
adhere to other cells and/or a substratum1. Fleming and colleagues have described biofilms as
an emergent form of bacterial life that differ substantially from free-living cells1. The properties
of biofilms cannot be predicted by the study of free-living bacteria alone, and are among the
most successful and ubiquitous life strategies on Earth1. All higher organisms, including
humans, are colonized by at least one organism observed to form biofilms1. These communities
are often high-cell density, containing over 108 cells per gram of wet weight1. The composition
of these biofilms can be highly heterogeneous, both in the species composition and the gene or
protein expression of the constituent cells1,2. This heterogeneity is driven by the interplay
between communication, co-operation, competition, and the occurrence of ecological
microgradients within the biofilm1–3. As a result, the biofilm matrix serves as an interface
between its constituents and their outside environment, serving many roles to the benefit of
the microorganisms that may justify the large resource cost of producing copious quantities of
extracellular matrix material1. For example, biofilms have been observed to serve in resource
capture1,4–6, accelerated cell growth7, and the tolerance of stressors or disinfectants, such as
shearing forces1,3,7, dessication1,8, antimicrobial compounds1,3,9,10, extreme temperature1,3,11, or
sanitizing agents1,3,4,9. Thus, biofilms not only confer emergent properties that have enhanced
the success of microorganisms on Earth, they provide constituent cells resilience, persistence,
and diversity1 that has made them a subject of research interest. For example, the formation of

CHARACTERIZING BcsG

9

biofilms by pathogens pose significant problems to human health, as biofilm formation can
occur within the host, on medical devices or implants, or on surfaces of healthcare facilities and
equipment1,3. In these environments, biofilms would confer enhanced resistance of these
pathogens to antimicrobial drugs and disinfectants commonly used to treat infection and
contamination, enhancing the survival of biofilms as compared to free-living cells1,3,12. Fux et al.
estimate that biofilms may be implicated in greater than 60% of resistant infections observed
by physicians in the clinic3, making them significant in the study of infectious disease. The
formation of biofilms has also been observed in many foodborne microbial pathogens,
enhancing their ability to persist through food preservation, packaging, and preparation or
cooking1. Thus, the persistence of foodborne pathogens or spoilage organisms may also result
in devastating economic losses through product recalls and workforce illnesses. The formation
of biofilms in water treatment facilities, water distribution pipes and on the surface of
underwater infrastructure also pose problems to human health and economics1,3. The study of
biofilms is not, however, limited to pathogens. Several biofilm-forming species have been
applied to the study of new materials13, wound dressings, polymer science, or water treatment
and biocontrol strategies1,13.
Microbial biofilms are considered a distinct form of life from motile and planktonic cells,
and the mechanisms that govern their formation have been reported extensively. Biofilms are
formed by planktonic cells through a reversible, then irreversible attachment to a substratum
and/or other cells via type IV pili, fimbriae or other cell-surface mediated adhesion
mechanisms11,14,15. Various cellular signalling events further drive cell division and
differentiation that results in the disassembly and downregulation of motility-associated
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factors, including flagella, and culminate in the secretion of exopolysaccharides and
proteinaceous factors that begin to enmesh the growing community16,17. Many independent
reports conclude that heterogeneity is largely responsible for the complex architecture
observed in mature biofilms16–18, forming highly ordered and differentiated three-dimensional
structures that include channels for the exchange of nutrients, solvent, gases, metabolic
wastes, and the flow of cells into or out of the biofilm. Metabolic differentiation also confers
important emergent properties to biofilms, including altered susceptibility to antimicrobial
drugs, the cooperative exchange of resources, and the accumulation of extracellular enzymes
that aid in defence, cooperativity and nutrient exchange1. Transitioning from a mature biofilm
to a planktonic cell or cells is also possible, and participation in a biofilm is a reversible process
as entry and exit to the biofilm phenotype is a dynamic and regulated process1.
Beyond the heterogeneity and the overwhelming diversity observed in biofilms, the
single unifying and defining characteristic of biofilms are the extracellular matrices that encase
the communities within them. Biofilm matrices themselves are complex, self-assembling
structures composed primarily of structurally diverse carbohydrates and proteins, but may also
include secreted extracellular DNA, lipids, and other non-structural molecules1. In addition to
these complex carbohydrate polymers, the existence of large, high molecular-weight amyloid
protein fibers has been described in large quantities1,5,10,11,19. The identity of the
exopolysaccharides that compose an individual biofilm is highly variable, with different
organisms producing different exopolysaccharides in their biofilms, both between and within
species1,20. Isolates of a single organism may produce different exopolysaccharides with vastly
different compositions under different conditions, or may produce no EPS at all under
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others1,14,20,21, and the presence of multiple genetic elements linked to the production of a
variety of EPS components within a single organism is also not uncommon1,14,22. For example,
the bacterium Pseudomonas aeruginosa is capable of producing the exopolysaccharides
alginate, Pel, and Psl, although not concomitantly23. Despite their apparent importance and
near-ubiquity, still little is known about the biochemical basis of EPS biosynthesis, export, and
self-assembly into the complex biofilm matrix. However, it is generally understood that EPS
biosynthesis is carried out by pathways described as “synthase-dependent”24. These pathways
are differentiated from others that function in the biosynthesis and export mechanisms of
other cell-surface carbohydrates in microorganisms, such as the cell wall, lipopolysaccharide, or
capsular polysaccharide24. These structural differences are attributed to the nature of the
polymer, where capsular or lipopolysaccharides are assembled on a lipid acceptor and are
shuttled to the cell surface where they remain attached, whereas, exopolysaccharides are
freely secreted at the cell surface and, thus, unique mechanisms for their biosynthesis are
necessitated23,24.

1.2 Synthase-dependent pathways
As described above, the composition of the biofilm matrix is variable between microbial
species, and in some cases, may also vary within a single species, as some organisms may
possess the means to produce multiple biofilm components under different conditions7. In
contrast, one unifying feature of these biofilms is that all matrix compositions described at
present contain some kind of carbohydrate component24. Many of these carbohydrate
components can be isolated as high molecular weight, unbranched polysaccharide chains24. The
biosynthesis of these EPS carbohydrate polymers do not share any physiological mechanisms
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with other well-studied bacterial metabolic pathways of other cell-surface carbohydrates, such
as lipopolysaccharide or capsular polysaccharide. For example, the Wzx-Wzy dependentpathway is used to assemble the cell-surface carbohydrate O antigen, found as the outer layer
of lipopolysaccharide in Gram negative bacteria (Fig. 1)25. In this system, glycosyltransferases
polymerize the base repeating saccharide chains of O antigen on a lipid acceptor, undecaprenyl
pyrophosphate (UndPP) on the cytoplasmic face of the inner membrane25. The Wzx flippase
then flips the UndPP lipid to the periplasmic face of the membrane via cation-driven antiport25.
The lipid-linked saccharide unit is transferred to the Wzy polymerase, where it adds a repeating
saccharide unit to the reducing end of the growing polymer, one unit at a time25. The length of
the polymer is then regulated by the Wzz protein, followed by ligation to the lipid A core of
lipopolysaccharide25. Alternatively, biosynthesis of other cell-surface polysaccharides, such as

Figure 1: Pathways for the biosynthesis & assembly of cell-surface glycans in Gram-negative bacteria.
Lipid-linked glycans, such as lipopolysaccharide or capsular polysaccharide, are assembled on lipid
anchors and shuttled to the outer membrane via the Wzx/Wzy dependent pathway (A) or by ATPbinding cassette (ABC) transport (B). Exopolysaccharides biosynthesis and export is instead carried out
by synthase complexes (C). PCP: polysaccharide co-polymerase, OPX: outer membrane polysaccharide
export, NDP/NMP: nucleotide diphosphate/monophosphate, OM: outer membrane, IM: inner
membrane, PG: peptidoglycan. Model adapted from Whitney and Howell (2013; Ref. 24).
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spore coat or capsular polysaccharide, is carried out in the cytoplasm by cytosolic
glycosyltransferases on lipid cores24, and translocation to the periplasm is carried out by ATPbinding cassette (ABC) transporters (Fig. 1)24,25. Export of these lipid-linked polysaccharides is
then carried out by the polysaccharide co-polymerase and outer membrane export systems, a
series of homologous systems in Gram-negative bacteria that transport a diverse set of lipidlinked glycans to the outer membrane of the cell26,27.
The free secretion of the EPS components at the cell surface differentiates them from
the above mentioned glycans and, thus, necessitates their unique biosynthetic pathways to be
independent of lipid acceptors. The biosynthesis of EPS components is instead thought to be
carried out by a series of pathways termed “synthase-dependent”, where the EPS is
polymerized at the inner membrane and transiently anchored to a synthase complex, allowing
for free secretion at the cell surface following polymerization and export24. Similar to the other
described cell-surface glycan biosynthesis pathways, these synthase-dependent pathways all
share common structural characteristics24,28, although the individual proteins responsible vary
based on the EPS they serve to polymerize and export. In Gram-negative bacteria, the focus of
this research, these synthase-dependent pathways form a trans-envelope complex24 spanning
the inner and outer membranes and traversing the periplasmic space (Fig. 1). In Gram-positive
organisms, these synthase complexes reside in the cytoplasmic membrane and facilitate the
direct export of the nascent polymer to the extracellular space.
At present, our understanding of the major components of the Gram-negative synthasedependent pathway include the involvement of a synthase complex24,29, an outer membrane
secretin complex24,28, and various periplasmic components found to be important for
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processing of the EPS polymer5,20,30,31. The polymerization of the EPS polymer is carried out by
the synthase complex, canonically containing a glycosyltransferase domain, responsible for
polymerizing the EPS from its metabolic precursor29, and a regulatory PilZ domain responsible
for binding cyclic dimeric guanosine monophosphate (c-di-GMP)9, an important second
messenger molecule in bacteria with a demonstrated physiological role in transcription of
community-associated genes and enzymatic activation of their gene products12,13.
Polymerization of the EPS glycan is linked to translocation through the synthase complex
and into the periplasm, where often the nascent polymer may be enzymatically modified by
transferases32, esterases33–35, epimerases36, hydrolases24,30,37, or a combination of these20.
Finally, export is carried out through an outer-membrane secretin28, composed of a β-barrel
porin24 in the outer membrane and a tandem-tetratricopeptide repeat (TPR), either as an
accessory domain to the porin, or as a separate protein anchored to the outer membrane28,38.
Together, these biosynthetic genes are operon-encoded, and are upregulated as part of the
motile-to-sessile physiological transition in response to cellular signalling events, typically
centered around c-di-GMP metabolism22.

1.3 Microbial cellulose
Among the diverse host of biofilm EPS components, microbial cellulose is one EPS matrix
produced by biofilm-forming bacteria of clinical and economic importance14. The cellulose
biofilm was first described in Gluconacetobacter xylinus (formerly Acetobacter xylinus), forming
a large pellicle composed chiefly of cellulose at the air-liquid interface39, and the later discovery
of cellulose in the well-studied human pathogens E. coli and Salmonella enterica14,19 highlight
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its importance. To date, the production of a biofilm composed of the exopolysaccharide
cellulose has shown importance to Acetobacter, Sarcina, Rhizobium, Agrobacterium,
Cronobacter and Pseudomonas species, among others, to form symbiotic and pathogenic
interactions5,40,41. Although they share the same name, bacterial cellulose is structurally distinct
from plant cellulose, as the former demonstrates malleability and high water-retention as
compared to the latter. These properties make bacterial cellulose highly useful for medical
applications and wound dressings, as a low cost natural product that can accelerate healing,
decrease pain, and greatly lowers the probability of infection for severe burns42. Because of its
inert and non-immunogenic nature, biocompatibility, and relative resistance to degradation,
bacterial cellulose has quickly become a major research topic in the modern biomedical
industry13.
Microbial cellulose is produced as a linear polymer of β-(1,4) linked glucose, although it
has been shown to be chemically modified in some cases43. In the case of unmodified microbial
cellulose, hydrogen bonding occurs between hydroxyl groups, facilitating the formation of
dense, fibrous and microcrystalline ultrastructure of the cellulose chains43. For this reason,
microbial cellulose has high tensile strength and low water retention, making it the subject of
study for materials science where it has seen application in wound dressings and stitches39,43,44.
Moreover, heterogeneity in the structure and assembly of cellulose biofilms have garnered
research interest into what shapes these discrete extracellular matrices and the specific
properties they confer to constituent bacteria. To date, at least three distinct subgroups of
microbial cellulose have been described5,32,45, which are discussed in further detail below, but
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all require the essential synthase-dependent components that assemble and export the
cellulose exopolysaccharide.

1.4 The bacterial cellulose synthase-dependent exopolysaccharide biosynthetic machine
All cellulose-producing bacteria possess the core bcsABCZ operon, or homologues
thereof, containing the essential biosynthetic machinery for the production and export of
cellulose chains, with the notable absence of outer-membrane localized components in Grampositive organisms43. The BcsA enzyme and its homologues have been demonstrated to be the
synthase component in the bacterial inner membrane, possessing processive
glycosyltransferase activity29. The identification of BcsA/BcsB as the catalytically active
glycosyltransferase and the resolution of the bacterial cellulose synthase by X-ray
crystallography represented significant milestones in the contemporary understanding of
bacterial cellulose biosynthesis29,46. The BcsA glycosyltransferase domain catalyzes the addition
of a single glucose residue at a time to the growing chain from a uridine 3’-diphosphate (UDP)
linked donor molecule, originating from the bacterial cytoplasm29. BcsA also possesses a PilZ cdi-GMP binding domain29, found in other c-di-GMP-responsive proteins6,22, responsible for
control of its glycosyltransferase activity. BcsB forms a heterodimer with BcsA and has been
shown to be necessary for BcsA activity and cellulose production both in vivo47 and in vitro29.
Together, the BcsA/B complex also facilitates the translocation of nascent cellulose chains to
the periplasmic space via a hydrophilic channel in BcsA and carbohydrate-binding domain in
BcsB29,48.
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Figure 2: The bacterial cellulose synthase biosynthetic machine. Polymerization of cellulose chains from
cytoplasmic UDP-glucose is carried out by the BcsA glycosyltransferase under positive regulation by the second
messenger molecule cyclic dimeric guanosine monophosphate (c-di-GMP). Periplasmic translocation is coupled
with synthesis and accomplished by the BcsA/BcsB heterodimer. Finally, export is achieved through the BcsC outer
membrane secretin. The periplasmic endoglucanase BcsZ is thought to be a negative regulator of the biofilm
phenotype and inversely expressed with the synthase components. Model based on Whitney and Howell (2013;
Ref. 24).

Secretion of the cellulose polymer across the outer membrane is necessary for Gramnegative organisms, and is thought to be carried out by a class of homologous secretin
complexes encoded on synthase-dependent operons24,38. The BcsC protein, and its synthasedependent homologues belong to this novel class of exopolysaccharide secretins28,38. A large βbarrel domain in the outer membrane forms a pore for export that matches the chemical
nature of the EPS polymer24. For example, BcsC is thought to form an uncharged hydrophilic
channel of 8Å diameter, suitable for cellulose secretion38, while AlgE of the alginate EPS system
possesses a series of positively-charged periplasmic loops to facilitate the movement of the
anionic alginate polymer49,50. A TPR region is also present in BcsC and other EPS synthase
homologues, and is thought to serve as a scaffold, both for assembling the synthase complex
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through protein-protein interaction as observed in other TPR-containing proteins, but also by
guiding the polymer through the periplasmic space and interacting with the peptidoglycan cell
wall in some way28,38. Finally, the BcsZ enzyme possesses endo-β(1-4)-glucanase activity,
colloquially referred to as a cellulase enzyme, and is responsible for degradation of cellulose
polymers from within the chain30,48. The activity of BcsZ may be responsible for suppression of
the biofilm phenotype and serve to initiate acute infection and virulence30, enabling rapid
transition to motility and host pathogenicity in some organisms. Also identified is the BcsQ
protein, thought to be a MinD homologue responsible for the polar localization of cellulose
synthase complexes at terminal cell poles and regulating the end-to-end cellular architecture
observed in biofilm phenotypes43.
An understanding of the regulation and assembly of the synthase complex remains
elusive, largely due to the complex and transient protein-protein interactions that shape it. At
present, it is understood that the assembly of synthase-dependent complexes occurs through
at least two distinct mechanisms: first, a molecular checkpoint ensures correct protein folding,
membrane insertion and protein-protein interaction of the synthase complex51, and
subsequently, c-di-GMP binding serves to both enzymatically activate the complex and promote
its proteolytic stability52,53. Furthermore, it appears that loss of c-di-GMP binding or complex
ultrastructure is correlated to downregulation of the synthase components and upregulation of
the BcsZ glycosyl hydrolase expression51, although its specific role, perhaps in periplasmic or
extracellular clearance of the cellulose exopolysaccharide remains to be demonstrated.
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1.5 Microbial crystalline cellulose
The initial discovery of microbial cellulose and the bcsABCZ operon in Acetobacter
xylinus enabled the identification of many more operons in a diverse subset of bacteria that
produce cellulose as part of their extracellular matrix40,54. Only following the description of
modified cellulose exopolysaccharides, and their biofilm phenotypes, did it become clear that
unmodified cellulose exopolysaccharides were responsible for a discrete biofilm morphotype of
their own. The identification of acsD in the proteobacterium Acetobacter hansenii and xcsB in
the cyanobacterium Thermosynechococcus vulcanus suggested that a periplasmic adaptor
protein may serve as a funnel for the coupling of individual cellulose fibrils into nanocrystalline
fibers, shaping the biofilm architecture of the unmodified cellulose exopolysaccharides45,55. The
apparent structural similarity of the XcsB periplasmic component of the cyanobacterial cellulose

Figure 3: Crystalline cellulose biosynthesis. The proposed bacterial cellulose synthase pathways in the
cyanobacterium Thermosynechococcus vulcanus (left) and the proteobacterium Acetobacter hansenii (left). The
presence of a periplasmic adaptor protein in these species may be related to the bundling of cellulose into
crystalline fibers in their biofilms. Adapted from Maeda et al (2018; Ref 45) and Hu et al. (2016; Ref 47).
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synthase to the HlyD component of bacterial tripartite efflux pumps suggest that cellulose
secretion in cyanobacteria may be mechanistically unique from the Proteobacteria45,56. Despite
this heterogeneity, numerous reports in the literature demonstrate that the essential
components for cellulose production include the synthase complex itself, and the outer
membrane secretin22,29,39,47, and that the lack of accessory periplasmic components is generally
correlated with the production of unmodified, crystalline cellulose nanofibrils in the biofilm.

1.6 Microbial acetylcellulose
The first report of microbial acetylcellulose was reported by Spiers and colleagues5 who
demonstrated that an unusual, “wrinkly spreader” biofilm phenotype of Pseudomonas
fluorescens SBW25 was driven by the production of a modified cellulose exopolysaccharide. In
addition to the operon-encoded, core synthase-dependent biosynthetic machinery needed to
produce cellulose, this organism also possessed additional genetic components whose deletion
resulted in the secretion of an unmodified cellulose exopolysaccharide with different physical
characteristics5. The acetylation of other carbohydrate polymers in bacteria has been described,
including pathways for the O-acetylation of the essential cell wall polymer peptidoglycan57,58 or
the O-acetylation of the exopolysaccharide alginate, first described in P. aeruginosa20,23. The
enzymes encoded on this acetylcellulose operon share sequence similarity with both the
bcsABCZ synthase complex and the algXFIJ acetylation pathway that produces the
exopolysaccharide alginate, a hemiacetylated polysaccharide consisting of (1-4)-linked β-Dmannuronic acid and α-L-guluronic acid also produced via a synthase-dependent system. Insight
into these mechanistic pathways of polymer O-acetylation have been reported extensively in
the literature and provide a structural and biochemical basis for acetylation of these polymers.
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Generally, an unknown acetyl donor, likely acetyl coenzyme A, provides the acetyl group to a
membrane-bound O-acetyltransferase (MBOAT) in the inner membrane20,23,58. This acetyl group
is then subsequently transferred to periplasmic protein components that serve to covalently
attach this acetyl group to the polymer in the periplasmic space20,58,59.
The essential functions for production and secretion of these acetylcellulose polymers are
carried out by the wrinkly spreader structural, or wssBCDE and wssFGHI operons, named so
after the multicellular morphotype their expression confers5. The wssBCDE operon encodes
predicted homologues of the bcsABCZ operon, including a synthase complex (wssB/wssC), an
outer membrane secretin (wssE) and a glycosyl hydrolase (wssD)5,20,23. The role of the wssFGHI
gene products in cellulose O-acetylation is not well understood at present, although their

Figure 4: Acetylcellulose biosynthesis. While the molecular mechanisms that govern cellulose O-acetylation have
yet to be elucidated, it is generally believed that the wssFGHI operon encodes a series of proteins responsible for
shuttling an acetyl group from a cytoplasmic donor, likely acetyl coenzyme A, to the exopolysaccharide in the
periplasmic space. Adapted from Whitney and Howell (2013; Ref 24).
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sequence similarity suggests they play an analogous role to the alginate O-acetylation proteins
algXFIJ, and to a lesser degree, to the Gram-negative peptidoglycan O-acetyltransferase
proteins patAB5,31. Initial acceptance of an acetyl group from a cytoplasmic donor by WssH,
which shares sequence similarities with the membrane-bound O-acetyltransferases PatA and
AlgI, whose function are well-characterized23,58. The shuttle of these acetyl groups from the
membrane-bound O-acetyltransferase to the nascent exopolysaccharide in the periplasmic
space is then carried out by WssF, WssI, and possibly WssG, evidenced by the sequence
similarity of these proteins to AlgX, AlgJ and AlgF, respectively5. These alginate Oacetyltransferase components have been shown to have separate and distinct roles in polymer
acetylation, despite having similar sequences and functional roles31.

1.7 Microbial phosphoethanolamine cellulose
The identification of phosphoethanolamine (pEtN) cellulose was reported by
Thongsomboon et al.32 based on discoveries by McCrate et al. that the extracellular matrix of E.
coli UTI89 harbors a modified form of cellulose10. Solid-state nuclear magnetic resonance
(NMR) experiments on the isolated extracellular matrix of E. coli demonstrated that its biofilm
was composed of amyloid curli fibers and pEtN cellulose32. Despite the acknowledgement of
cellulose synthase operons in the Enterobactericeae11,22,39,60, it was long thought that these
organisms produced unmodified cellulose strands as the pEtN evaded detection by traditional
methods, often lost by treatments with acid or base that were commonplace in the isolation of
the matrix material from the biofilm32. Instead, the mature polymer isolated from several
strains of pathogenic E. coli and Salmonella enterica is a cellulose chain of which every-other
glucose unit is substituted at the C6 hydoxyl with an O-phosphorylethanolamine group32.
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Similar to the phenomenon observed in acetylcellulose5, this modification with
phosphoethanolamine conferred unique physical properties to the biofilm that were lost with
its absence, and these properties appear important in the colonization of hosts of pathogenic
Enterobactericeae32,61
The biochemical basis for the phosphoethanolamine substitution of microbial cellulose
has not yet been demonstrated. However, an additional bcsEFG operon has been reported
adjacent to the bcsABCZ operon in many cellulose-producing members of the
Enterobacteriaceae, termed Type II operons in the literature22,60. Until recently, the role of this
secondary bcsEFG operon remained largely unknown. Romling et al. reported that deletion of
the operon in S. enterica demonstrated reduced, but detectable cellulose production39. Fang et
al.62 reported that the BcsE protein represented a new class of c-di-GMP receptors62.
Thongsomboon et al.32 further demonstrated that deletion of bcsG, and to a lesser degree, bcsE
and bcsF resulted in a reduction or loss of phsophoethanolamine substitution of cellulose in E.
coli and S. enterica. The proposed model of bcsEFG involves assembly into an inner membranespanning complex responsible for phosphoethanolamine substitution of microbial cellulose.
This complex is suggested to be regulated by c-di-GMP binding, independently of the BcsAB
synthase complex32. Sequence analysis and mutagenesis suggest that bcsG encodes the key
phosphoethanolamine transferase enzyme responsible for the covalent phosphoethanolamine
modification of the cellulose exopolysaccharides in the Enterobacteriaceae32.
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Figure 5: Phosphoethanolamine cellulose biosynthesis. The accessory bcsEFG operon in the Enterobacteriaceae is
proposed to encode a novel c-di-GMP receptor and a phosphoethanolamine transferase responsible for
modification of the exopolysaccharide. PtdEtN: phosphatidylethanolamine, DAG: diacyldlycerol, pEtN:
phosphoethanolamine. Adapted from Thongsomboon et al. (2018; Ref 32).

1.8 Phosphoethanolamine transferases
The substitution of polysaccharides with pEtN outside the context of this research has
been described in the literature. Several pEtN transferases that serve to substitute
lipopolysaccharide with pEtN have been reported63–66. Lipopolysaccharides are high-molecular
weight glycolipids composed of a lipid A glycophospholipid, an inner and outer core branched
glycan, and an outer unbranched glycan repeating unit. Lipopolysaccharides are also antigenic
determinants – the outer repeating glycan units of these molecules referred to as “O antigen”,
as the lipopolysaccharide layer of unique bacterial isolates demonstrate significant structural
variability both between species or strains and across isolates of the same species or strain67.
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The lipid A component is synthesized by a conserved pathway of nine sequential enzymes67 that
assemble the metabolic precursor, UDP-N-acetylglucosamine into lipid A-Kdo2, which becomes
the ultimate acceptor of core sugars67,68. Lipid A structure may vary widely both within and
between species based on subtle structural changes in the lipid A biosynthetic enzymes and
their regulation67. The surface O-antigen is assembled separately, and varies based on the
activity of many diverse glycosyltransferases, and is often strain specific with over 160
described O-antigen variants found in E. coli alone64,68. Further variability of the mature LPS
structure is attributable to the activity of aforementioned phosphoethanolamine transferases
that further decorate these glycans, either at the lipid A glycophospholipid, or the core
saccharides, and enhance their variability64,68–71.

Figure 6: Lipid A and lipopolysaccharide structure. The addition of pEtN to lipid A (left), or to core
oligosaccharides (right) of the mature lipopolysaccharide molecule confers resistance to polymyxins,
cathelicidins, and alpha- or beta-defensins. A representative lipopolysaccharide structure from E. coli
K12 is shown based on work by Washazaki et al. (2016; Ref. 71), with phosphorylation or pEtN
modification sites annotated in red.
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The strong negative charge of the lipid A glycophospholipid at the cell surface serves as
the binding site for cathelicidins; antimicrobial peptides of the vertebrate innate immune
system, defensins; antimicrobial peptides found in vertebrates, invertebrates and some plants,
and polymyxins; a class of cyclic, cationic antimicrobial peptides (CAMPs) targeting Gramnegative bacteria66,72. Pertaining to this study, polymyxins are naturally produced by various
members of the genus Bacillus subgenus Paenibacillius and have been used as clinical
antimicrobial drugs due to their high potency, causing cell death in milligram per liter
conentrations66,73. The binding of polymyxins to lipopolysaccharides induces destabilization of
the cell membrane, leading to increased permeability, cell death, and lysis74. The efficacy of
these polymyxins is dependent upon the electrostatic interaction between the positively
charged polymyxin and the negative charge of the phosphate groups of lipid A on the cell
surface65. Thus, in bacteria that share an environmental niche with Paenibacillius, the
emergence of a mechanism to shield the strong negative charge of the lipid A phosphate
groups confers resistance to these peptides, and subsequntly, considerable selective advantage
in such an environment75,76. The action of characterized pEtN transferases on these lipid A serve
such a role, where a covalent pEtN modification shields the negatively charged phosphate that
serves as the peptide binding site, both sterically with the ethyl linkage, and electrostatically
with a positively charged amine group77.
Today, polymyxins have been repurposed extensively for clinical use as a natural
product antimicrobial73,75,76. Despite being nephrotoxic, polymyxins are classified as antibiotics
of critical importance by the World Health Organization due to their activity against the rising
threat of multidrug resistant Gram negative bacteria73. However, many species are or have
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become intrinsically resistant to polymyxins, such as Neisseria meningitidis, Campylobacter
jejuni, Burkholderia cepacian, and others75,76. The increased use of polymyxins in the clinic or
for broader industrial purpose has been causally linked to the emergence of these lipid A pEtN
transferases encoded on transferable multidrug resistance plasmids, disseminated through
human pathogens, such as E. coli, P. aeruginosa, or Klebsiella pneumoniae, among others76. The
flagship example, reported on widely in the literature, are the mobile colistin resistance (MCR)
factors72,76. Based on sequence analysis, these phosphoethanolamine transferases consist of an
N-terminal transmembrane domain that anchors them in the inner membrane of Gramnegative bacteria and contain a C-terminal domain belonging to the alkaline phosphatase
superfamily, which is localized to the periplasmic face of the inner membrane. Several of these
polymyxin resistance factors have been structurally resolved and biochemically characterized.
These enzymes modify nascent lipopolysaccharide co-synthetically, using the membrane lipid
phosphatidylethanolamine as a donor of the modification65, first binding to the lipid via the Nterminal transmembrane domain and cleaving the pEtN group, liberating diacylglycerol78. These
enzymes are then predicted to proceed through a ping-pong double-displacement mechanism,
characterized by a covalent pEtN-enzyme intermediate thats transfers the pEtN to its ultimate
lipid A acceptor72, although the evidence for this mechanism remains limited. Furthermore,
these enzymes possess a conserved binding site for one or more zinc cations in their active
sites, canonical of related phosphotransferases65. This model for activity is presumed to be
conserved throughout all known pEtN transferases, and by extension, serves as the proposed
model for BcsG structure, activity, and mechanism.
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2. Research Need and Hypotheses
Antimicrobial-resistant infections are predicted to be the leading cause of death worldwide
by 2050, surpassing annual mortality by cancer and cardiovascular disease79. The emergence
and spread of resistance to clinical antimicrobial drugs by numerous pathogens has become a
widespread and worsening public health problem80. Such an emergence of common infections
resistant to first- and second-line antibiotic treatment options necessitates the use of drugs by
clinicians that may be more costly, more toxic to the patient and less efficacious for treating the
infection80. Furthermore, infections are being presented in the clinic that are becoming
increasingly multidrug resistant, further reducing the treatment options available, and cases
have been reported of several pathogens that are completely recalcitrant to all known classes
of antimicrobial drugs80.
The discovery of new molecular targets for clinical therapeutics and the development of
novel therapeutic strategies to treat multidrug resistant infections is imperative to combat the
rising threat of antimicrobial resistance81. Biofilms serve as the first line of defence for their
constituents, and biofilms have a demonstrated role in the colonization of the host in several
pathogens of clinical significance – for example, Fux et al. have estimated biofilms to be
implicated in greater than 60% of infections observed by physicians in the clinic3. Furthermore,
the biofilm matrix itself offers both direct and indirect mechanisms to enhance the resistance of
its constituents to clinical antimicrobial drugs1,8,82,83. These properties make biofilms an
attractive potential target for novel therapeutics, where disruption of the biofilm may improve
the efficacy of antimicrobial drugs against resistant pathogens or may serve as a novel
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treatment to attenuate recalcitrant infections. The development of biofilm dispersal strategies
may serve to improve treatment outcomes for patients dependent solely upon contemporary
treatments centered around bactericidal drugs that are rapidly losing efficacy. Strategies based
upon disruption of bacterial biofilms using the glycoside hydrolases encoded by bacteria
themselves have been demonstrated in the literature to be correlated with improved
treatment outcomes in various infection models and proof-of-concept experiments84–86.
Pertaining to this research, the discovery of bcsG as the essential genetic component for
synthesis of pEtN cellulose and, thus, the architecture and assembly of the biofilm matrix makes
BcsG an attractive target for such structure-based drug discovery. The role of pEtN cellulose in
host colonization by the clinically important pathogens E. coli and S. enterica further
demonstrate the research need for an understanding of the chemical biology of pEtN cellulose
biofilms. Small molecule inhibitors of bcsG-directed pEtN cellulose biosynthesis may serve to
attenuate the host colonization potential of multidrug resistant pathogens, serving important
clinical roles in the treatment of antimicrobial-resistant infections that pose a rising global
threat to public health.
Furthermore, an understanding of bcsEFG-directed pEtN cellulose production may
enable biosynthetic engineering of new cellulosic materials or confer the advantages of pEtN
cellulose in new organisms. pEtN cellulose evaded detection through decades of microbial
cellulose research owing largely to the harsh acid hydrolysis procedures for isolating the matrix
material10. Only recently have pEtN cellulose and the role of the bcsEFG operon been identified,
and our understanding of this modification remains in its infancy. The biochemical basis of BcsG
activity and the structure of the BcsEFG complex remain unexplored.
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We hypothesize that BcsG is functionally homologous to the phosphatidylethanolamine
lipooligosaccharide transferases, catalyzing the metal-dependent transfer of lipid head groups
to a cellulose exopolysaccharide acceptor. We also hypothesize a structural and biochemical
characterization of BcsG will lead to a greater understanding of the mechanism of cellulose
pEtN modification and the underlying molecular mechanisms of bacterial cellulose biosynthesis.

3. Objectives
The objective of this thesis is to investigate the chemical biology of pEtN cellulose in bacteria.
The research will focus on the gene product of bcsG from the model organism and clinically
important human pathogen E. coli. In order to gain a meaningful understanding of this
phenomenon, the thesis addresses three key objectives: a structural characterization of BcsG
through crystallization, X-ray diffraction (XRD) analysis and structural modelling; a functional
characterization of BcsG through in vitro activity assays; and an understanding of the catalytic
mechanism of BcsG.

3.1 Structural characterization
At the onset of this thesis, no homologous structure of BcsG was available. During this
work, the structure of BcsG from S. typhimurium (StBcsG) was solved independently. The work
presented here expands on the knowledge of StBcsG in three distinct ways. First, a structural
model of the E. coli phosphoethanolamine transferase would provide significant insight to the
enzyme fold, the catalytic mechanism, and the architecture of the active site pocket in a second
model organism of the Enterobacteriaceae. The resolution of the EcBcsG catalytic domain
would inform further studies aimed at elucidating its function, interpreting its relationship to
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other phosphotransferase enzymes, and designing small molecule inhibitors of BcsG activity.
Because of the significant contributions to the current knowledge mentioned above that such a
model would provide, a structural characterization of the BcsG catalytic domain from the model
organism E. coli is a primary aim of this thesis.

3.2 Functional characterization of BcsG
The bcsG gene has been established as the essential genetic component required for
phosphoethanolamine production in the extracellular matrix of E. coli and S. enterica. However,
at the time of writing, the enzymatic activity of BcsG had never before been demonstrated. To
test the hypothesis that BcsG is a phosphoethanolamine transferase, a key objective of this
thesis was to establish that the C-terminal catalytic domain of BcsG is capable of this enzymatic
activity.

3.2 Catalytic investigation
An understanding of the catalytic mechanism and the active site architecture is essential to
unlocking the secrets of bcsG-directed phosphoethanolamine cellulose. At present, the active
site and catalytic mechanism of other phosphoethanolamine transferases have been proposed
and are supported by experimental evidence. Using this data as a model for the catalytic
function and architecture of BcsG, this thesis will address the molecular mechanism of pEtN
cellulose.
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4. Experimental Methods
4.1 Recombinant protein production
The full-length open reading frame of bcsG from E. coli K12 (EcBcsG) and a truncated bcsG
comprised of the nucleotides encoding amino acids Ala164 to Gln559 (EcBcsGΔN) were
generated via subcloning into the pET28a overexpression vector according to the protocol by
Cohen et al. (1973)87 to generate pBcsG and pBcsGΔN, respectively. Site-directed mutagenesis of
these recombinant plasmids at predicted active-site residues were generated using the
polymerase chain reaction (PCR) primer method described by Hutchison et al. (1978)88 with the
QuikChange II SDM kit supplied by Agilent Technologies and according to the manufacturer’s
protocol using synthetic oligonucleotide primers supplied by the University of Guelph
Laboratory Services facility, Guelph, ON to produce the plasmids listed in Table 1 below. All
plasmids were sequence verified at the Centre for Applied Genomics, University of Toronto,
Toronto, ON. Summary information for the EcBcsG and EcBcsGΔN recombinant constructs are
available in Table 2 below. A list of experimental and laboratory strains of E. coli used in this
study are listed below in Table 3.

Figure 7: Predicted EcBcsG topology, containing a putative N-terminal transmembrane domain and a Cterminal catalytic domain.
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Table 1: Recombinant plasmids and oligonucleotide primers used in this study
Plasmid
Relevant description
Oligonucleotide primer sequence(s) (5’-3’)
pBcsG
Recombinant enzyme
F:GGCGCATATGACTCAATTTACGCAAAATACC
R:GCGCCTCGAGTTACTGCGGGTAAG
pBcsG C243A
Metal-binding mutant
F:CTACTGGTGATTAACATCGCGTCGCTTTCCT
GGTCGGATATAG
R:CTATATCCGACCAGGAAAGCGACGCGATGT
TAATCACCAGTAG
pBcsG Y277A
Substrate-binding mutant
F:CCACCTCCGCGAGTGGCCCGGCGGCGATC
R:GATCGCCGCCGGGCCACTCGCGGAGGTGG
pBcsG Y277F
Substrate-binding mutant
F:GCCACCTCCTTCAGTGGCCCGGCGGCGATCC
R:GGATCGCCGCCGGGCCACTGAAGGAGGTG
GC
pBcsG S278A
Catalytic mutant
F:CCACCTCCTACGCGGGCCCGGCGGC
R:GCCGCCGGGCCCGCGTAGGAGGTGG
pBcsG C290A C306A
Disulfide bond mutant
pBcsG F329A
Substrate-binding mutant
F:GATGGGACATAACGGCCAGGCGGGCGGTTT
TTTGAAAG
R:CTTTCAAAAAACCGCCCGCCTGGCCGTTATG
TCCCATC
pBcsG H396A
Substrate-binding mutant
pBcsG E442A
Metal-binding mutant
F:GGTCGTGGTGCCGGCACACGGCGGCGCG
R:CGCGCCGCCGTGTGCCGGCACCACGACC
pBcsG H443A
Metal-binding mutant
F:GTCGTGGTGCCGGAAGCGGGCGGCGCGC
R:GCGCGCCGCCCGCTTCCGGCACCACGAC
pBcsGΔN
Recombinant catalytic
F:GGCGCATATGACTCAATTTACGCAAAATACC
domain
R:CTCCTTGCATATGGCGGGACAACC
pBcsGΔN C243A
Metal-binding mutant
F:CTACTGGTGATTAACATCGCGTCGCTTTCCT
GGTCGGATATAG
R:CTATATCCGACCAGGAAAGCGACGCGATGT
TAATCACCAGTAG
pBcsGΔN Y277A
Substrate-binding mutant
F:CCACCTCCGCGAGTGGCCCGGCGGCGATC
R:GATCGCCGCCGGGCCACTCGCGGAGGTGG
pBcsGΔN S278A
Catalytic mutant
F:CCACCTCCTACGCGGGCCCGGCGGC
R:GCCGCCGGGCCCGCGTAGGAGGTGG
pBcsGΔN H396A
Substrate-binding mutant
F:CTACAACACGCTTCCACTGGCGGACGGCAA
CCATTATCC
R:GGATAATGGTTGCCGTCCGCCAGTGGAAGC
GTGTTGTAG
pBcsGΔN E442A
Metal-binding mutant
F:GGTCGTGGTGCCGGCACACGGCGGCGCG
R:CGCGCCGCCGTGTGCCGGCACCACGACC
pBcsGΔN H443A
Metal-binding mutant
F:GTCGTGGTGCCGGAAGCGGGCGGCGCGC
R:GCGCGCCGCCCGCTTCCGGCACCACGAC
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Source
This study
This study

This study
This study
This study
BioBasic
This study

BioBasic
This study
This study
This study
This study

This study
This study
This study

This study
This study

F: forward primer, R: reverse primer, restriction sites and mutations denoted by underline
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Recombinant plasmids were introduced into chemically competent E. coli BL21 (DE3)
supplied by Novagen as an expression host (Table 3) by incubating a mixture of cells and
plasmid at 42°C for 1 min. These cells were allowed to recover at 4°C for 5 min, followed by
incubation at 37°C in 500 µL of Lauria Broth (LB) media (10 g tryptone, 5 g yeast extract, 10 g
NaCl per liter of culture). The resulting culture was spread on LB agar plates (LB plus 15g of agar
per liter of media) containing 50 µg/mL kanamycin and incubated at 37°C for 12-18 h to select
for successful transformants. Pure colonies were picked from this plate and used to inoculate
20 mL of LB containing 50 µg/mL kanamycin per liter of culture. This media was incubated 1218 h (or until turbid) at 37°C with shaking at 220 rotations per minute (rpm). These cultures
were used to inoculate each liter of Super Broth (SB) media (32 g tryptone, 20 g yeast extract,
10 g NaCl per liter of culture) containing kanamycin at a final concentration of 50 µg/mL. These
cultures were incubated at 37°C and 220rpm until an optical density at 600nm (OD600) of > 0.6
was reached. Expression was induced by the addition of isopropyl-β-D-1-thiogalactopyranoside
(IPTG) of 1mM, as expression of the recombinant gene is under the control of the inducible T7
overexpression system encoded on the pET28a plasmid. Cells were harvested by subjecting the
culture to centrifugation at 5000 x g for 15 min, decanting the supernatant, and storing the
resulting pellet at -20°C until needed.
Table 2: Recombinant proteins used in this study
Construct
Molecular mass (Da)†
Length (residues)
Predicted pI†
Extinction coefficient (M-1 cm-1) λ=280 nm†
His-tag
†
Values estimated by ProtParam tool89

EcBcsGΔN
45345
417
6.11
122965
N-terminal

EcBcsG
62086
581
6.04
49390
N-terminal
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Table 3: Strains used in this study.
Strain
Genotype
E. coli TOP10
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15
ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697
galE15 galK16 rpsL(StrR) endA1 λ-

Source or reference
Invitrogen

E. coli BL21

B F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3
[lacI lacUV5-T7p07 ind1 sam7 nin5]) [malB+]KS
12(λ )

Novagen

E. coli AR3110

K-12 W3110 ΔbcsQ::bcsQ
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E. coli AR3110 ΔbcsG AR3110 bcsG::scar
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4.2 Cell lysis and recombinant protein purification
Cell pellets were resuspended to homogeneity in a minimal volume of buffer A (50 mM
Tris, 300 mM NaCl, 5 mM MgCl2 pH 8.0), typically 20 mL / L culture. Cell lysis was performed on
this suspension using a Constant Systems cell disrupter operating at 17kpsi. The soluble cellular
fraction was isolated from the crude lysate by subjecting it to centrifugation at 28000 x g for 45
min to remove insoluble debris. Initial His6-tagged protein purification from the soluble cellular
fraction was performed by immobilized metal ion affinity chromatography (IMAC). The soluble
cellular fraction containing the recombinant EcBcsGΔN-His6 tagged fusion proteins was
incubated in 1-3 mL nickel-nitrilotriacetic acid agarose (Ni-NTA) resin for 1 h at 4°C. The mixture
was passed over an open column to separate the Ni-NTA from the unbound cellular fraction.
The Ni-NTA was washed with 50 mL of buffer A, followed by washing in 50 mL of wash 1 buffer
(buffer A with the addition of 20 mM imidazole) to remove unwanted contaminants. His6tagged protein was eluted from the column by the addition of 20 mL of elution buffer (buffer A
with the addition of 250 mM imidazole) to the resin.
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Purification to homogenity was performed using size exclusion chromatography (SEC) or
ion-exchange chromatography (IEC) where deemed necessary. Ion exchange chromatography
was performed on a GE Akta Pure instrument using a GE Q FF HiTrap anion exchanger. Eluted
protein from IMAC purification was buffer exchanged with dialysis 12 h against 50 mM Tris-HCl
pH 8.0 and the sample was passed over the column twice to facilitate binding. Protein was
eluted with a gradient of 50 mM Tris-Hcl pH 8.0 with increasing concentrations of sodium
chloride, up to 1 M. Fractions containing protein, typically eluting in the range of 75-150 mM
NaCl, were pooled. Size exclusion chromatography was performed on a GE Akta Pure
instrument using a BioRad Enrich SEC 650 column. His6-EcBcsG from IMAC purification was
dialyzed against SEC buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 mM MgCl2) for 12 h. The
resulting protein solution was concentrated to a volume of 1 mL using a GE Healthcare
centrifugal concentrator (30,000 Da molecular weight cut-off) and loaded onto the SEC column.
The protein was eluted with SEC buffer at a rate of 1 mL min-1 and fractions containing protein
were pooled. The purity of protein after each purification step was assessed using SDS-PAGE
according to the protocol by Laemmli (1970)90. Protein quantification was performed with UV
spectrophotometry (λ = 280 nm) using a BioTek Cytation 5 imaging microplate reader and the
molar extinction coefficients listed in Table 2.

4.3 Functional bioassay
4.3.1 Synthesis of paranitrophenyl phosphoethanolamine. A solution of 1.1 mL (7.11 mmol) N(tert-butoxycarbonyl) ethanolamine (N-Boc ethanolamine) was prepared in 20 mL of anhydrous
tetrahydrofuran (THF). This mixture was slowly added to a vaccuum-purged and stoppered 50
mL round bottom flask containing a solution of 3.65 g paranitrophenyl phosphodichloridate and
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2.30 mL anhydrous pyridine in 35 mL anhydrous THF as solvent. The mixture was placed at 4°C
for 1 h, and then placed at 20°C for a minimum of 7 h with agitation. A solution of 2.3 mL
pyridine in 10.2 mL of water was added to this reaction mixture for 10 min with agitation.
Following this incubation, the solvent was removed by rotary evaporation under vacuum,
producing a faintly yellow liquid organic phase with an approximate volume of 10 mL. This
organic intermediate was diluted in approximately 50 mL of water and washed in at least three
50 mL volumes of ethyl acetate. The aqueous phase was acidified with two 50 mL volumes of
5% w/v potassium bisulfate until a pH of between 3 and 4 was achieved. The desired organic
product was extracted with three 50 mL volumes of methylene chloride. The extracted organic
phase was washed with one 50 mL volume of saline water, dried over sodium sulfate, and
concentrated by rotary evaporation under vacuum. This reaction intermediate was sampled
and dissolved in deuterated chloroform for analysis by H1, C13 and F19 nuclear magnetic
resonance (NMR) spectroscopy on an Agilent 400 MHz spectrometer. To cleave the N-Boc
protecting group, a 72 mg quantity of the dried intermediate was dissolved in a mixture of 1 mL
methylene chloride containing 0.1 mL trifluoroacetic acid and stirred at 20°C for at least 1 h.
The reaction mixture was concentrated by rotary evaporation under vacuum and the residue
was triturated with two volumes of 1 mL of ethyl acetate. The resulting product crystallized as a
fine white crystalline solid of paranitrophenyl phosphoethanoamine (p-NPPE) trifluoroacetate.
The crystals were washed and recrystallized in ethyl acetate. The identity of the organic product
was verified by dissolving a small quantity in deuterated DMSO and analyzing by NMR
spectroscopy as described above.
4.3.2 Cellulose transferase assay. Purified EcBcsGΔN was incubated with p-NPPE as the donor of
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the phosphoethanolamine group and cello-oligosaccharides as the ultimate acceptor for the
transferase reaction. Unless otherwise specified, the reaction conditions were assayed with 50
µM EcBcsGΔN in a 96-well microtiter plate (Sarstedt) using a total well volume of 100 µL with a
buffer solution containing 50 mM HEPES pH 7.5 and 50 mM sodium chloride. The reaction
mixtures were incubated at 37°C for 30 min and monitored every 1 min for their absorbance at
414 nm. A standard curve (0 -100 µM) was prepared by dilution of a para-nitrophenolate
standard solution (10 mM, Sigma) and used to calculate molar equivalents of paranitrophenolate released by enzymatic activity. Negative controls were prepared with the
absence of EcBcsGΔN from reaction mixtures. Kinetics were performed with variable
concentrations of p-NPPE (0-10 mM) and cellopentaose (0-2.5 mM) as specified. Kinetic
parameters were calculated using GraphPad Prism. The esterase activity of EcBcsGΔN was
measured in the absence of cello-oligosaccharides in the reaction mixture, whereas transferase
activity was measured indirectly in the presence of both donor and cello-acceptor substrates.
Dithiothreitol (DTT; 1 mM) and ethylenediaminetetraacetic acid (EDTA; 1 mM) were introduced
to EcBcsGΔN by buffer exchange for at least 12 h prior to measurement of the enzymatic rate.
All measurements were repeated in at least triplicate.
4.3.3 Thin-layer chromatography. Samples from the cellulose transferase assay were prepared
for thin-layer chromatography (TLC) by centrifugation at 10,000 x g for 5 minutes to remove
precipitate. The pellet was discarded, and the supernatant was retained as the analytical
sample. Samples were spotted onto silica plates (Sigma) with samples at 1 cm intervals, a
minimum distance from the solvent line of 1 cm using glass capillary tubes approximately 4-8
times and allowed to dry 10 min between spots. The mobile phase used to separate the
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enzymatic products was a solution of ethyl acetate, water, and methanol in an 8:3:4 ratio,
respectively. The plate was placed in a 10 L tank, vapor-equilibrated with 50 mL of mobile phase
and allowed to run until the solvent front reached 1 cm from the top of the plate,
approximately 45 min – 1 h. The plate was dried by heating at 90°C on a hot plate and stained
in a solution of 1 g/L α-napthol dissolved in methanol, sulfuric acid and water in a 25:3:2 ratio,
respectively. The stain was developed by heating at 90°C for 5 minutes or until spots were
visible.
4.3.4 Liquid chromatography-mass spectrometry (LC-MS).
Liquid chromatography–mass spectrometry analyses were performed on an Agilent 1200 HPLC
interfaced with an Agilent UHD 6530 Q-ToF (quadrupole time-of-flight) mass spectrometer at
the Mass Spectrometry Facility of the Advanced Analysis Centre, University of Guelph. A C18
column (Agilent Extend-C18 50 mm x 2.1 mm 1.8 µm) was used for chromatographic separation
with the following solvents: water with 0.1% (v/v) formic acid (A) and acetonitrile with 0.1%
(v/v) formic acid (B). The mobile phase gradient was as follows: initial conditions were 10% B
hold for 1 min then increasing to 100% B in 29 min followed by column wash at 100% B for 5
min and 20 min re-equilibration. The flow rate was maintained at 0.4 mL/min. The mass
spectrometer electrospray capillary voltage was maintained at 4.0 kV and the drying gas
temperature at 250° C with a flow rate of 8 L/min. Nebulizer pressure was 30 psi and the
fragmentor was set to 160. Nozzle, skimmer and octapole RF voltages were set at 1000 V, 65 V
and 750 V, respectively. Nitrogen (purity >99%) was used as both nebulizing, drying and
collision gas. The mass-to-charge ratio was scanned across the m/z range of 50-1500 m/z in 4
GHz (extended dynamic range) positive and negative ion modes. Data were collected by data
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independent MS/MS acquisition with an MS and MS/MS scan rate of 1.41 spectra/sec. The
acquisition rate was set at 2 spectra/s. The mass axis was calibrated using the Agilent tuning
mix HP0321 (Agilent Technologies) prepared in acetonitrile. Mass spectrometer control, data
acquisition and data analysis were performed with MassHunter® Workstation software
(B.04.00).
LC-MS/MS analysis of tryptic peptides. LC-MS/MS (liquid chromatography tandem mass
spectrometry) analyses were performed on an Agilent 1200 HPLC interfaced with an Agilent
UHD 6530 Q-TOF mass spectrometer. Separation of the peptides was achieved by reversephase HPLC using a C18 column (Agilent AdvanceBio Peptide Map, 100 mm × 2.1 mm 2.7 μm)
previously equilibrated with 2% (v/v) acetonitrile in 0.1% (v/v) formic acid at a flow rate of 0.2
mL min−1. Following injection of samples, a linear gradient to 45% (v/v) acetonitrile in 0.1% (v/v)
formic acid was applied over 40 min and then to 55% (v/v) acetonitrile over 10 min. The column
was washed with 95% (v/v) acetonitrile in 0.1% (v/v) formic acid for 5 min before reequilibration in starting solvent. The mass-to-charge ratio was scanned across the m/z range of
300−2000 m/z in 4 GHz (extended dynamic range positive-ion auto MS/MS mode). Three
precursor ions per cycle were selected for fragmentation. The instrument was calibrated with
the ESI TuneMix (Agilent). Raw data files were loaded directly into PEAKS 7 software
(Bioinformatics Solutions Inc.) where the data were refined and subjected to deNovo
sequencing and database searching. The following modifications were considered within the
search parameters: Met oxidation, and phosphorylation or pEtN-ylation of Thr, Ser, Cys, Tyr,
and His residues. The data were searched against the EcBcsG sequence. The tolerance values
used were 10 ppm for parent ions.
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4.4 Functional complementation
Cell lines. E. coli AR3110, W3110 (AR3110 bcsQ::Stop), AR3110 ΔbcsG ΔcsgBA (AR3110
bcsG::scar, csgBA::kanR), AR3110 ΔbcsG (AR3110 bcsG::scar) and AR3110 ΔcsgBA (AR3110
csgBA::kanR) were received from Thongsomboon and Cegelski (Standford U) as a gift. E. coli
AR3110 ΔbcsG was made chemically competent by first culturing in TYM broth (2% [w/v]
tryptone, 0.5% [w/v] Yeast extract, 0.1 M NaCl, 10 mM MgSO4) until an OD600 > 0.6 was
reached. The cells were harvested by centrifugation and washed in TfB I media (10 mM MOPS,
75 mM CaCl2, 10 mM KCl, 15% [v/v] glycerol, pH 7.0). The harvested cells were resuspended in
TfB I media and stored at -80°C in 50 µL aliquots. These aliquots were transformed with plasmid
according to the protocol outlined above in Section 4.1. Cell lines expressing protein variants of
EcBcsG were generated by transforming the pBcsG derivates, whose construction is described
in Section 4.1 above, into chemically competent E. coli AR3110 ΔbcsG.
Pellicle macrocolony phenotype. Biofilm phenotype was assessed in triplicate by inoculating 5
mL of salt-free LB broth containing 50 µg/mL kanamycin and incubating for 5 d at 28°C. The
resulting biofilms were removed from the tubes by pouring in glass beakers, discarding the
culture media, and staining the biofilms in a solution of 40 µg/mL Congo Red for at least 10 min.
The biofilms were then washed in water and imaged on a Bio-Rad VersaDoc 4000 instrument
using both a visible white-light filter.
Adherence assay. The adherence potential of biofilms were assessed semi-quantitatively using
a crystal violet assay. Eight replicates of each cell line were inoculated into 96-well microtiter
plates with each well containing 250 µL of salt-free LB broth containing 50 µg/mL kanamycin
and the plates incubated for 5 d at 28°C. The media was removed and the biofilms were
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washed in three 200µL volumes of sterile phosphate buffered saline (12 mM sodium
phosphate, 137 mM sodium chloride, pH 7.4), then stained in 200 µL of 0.1% (v/v) crystal violet
solution. The residual crystal violet was washed away with 3 x 200 µL volumes of sterile
phosphate buffered saline and allowed to dry for 1 h. The stained biofilm was resolubilized in
200 µL of 30% (v/v) acetic acid and the absorbance was measured at 550 nm in a BioTek
Cytation5 imaging plate reader.
Expression of recombinant EcBcsG. Biofilms were grown in 96-well microtiter plates containing
200 μL of salt-free LB with 50 μg/mL kanamycin and 250 μM IPTG at 28°C for 96 h. The biofilms
were harvested by mechanical disruption (i.e. aspiration by micropipette) and subsequent
ultracentrifugation at 21,100 x g for 5 min. To prepare the samples for Western blotting
analysis, the culture media was removed, and the pellets were resuspended in SDS sample
buffer (50 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, 1 mM DTT, 0.02% w/v
bromophenol blue) and lysed by heating at 100°C for 1 h. To assess the cellular quantity of
EcBcsG supplied in trans, these samples were immunoblotted according to the protocol by
Burnette (1981)91 with an antibody against the His-tag conferred by expression from the
pET28a vector. Briefly, SDS-PAGE gels were soaked in transfer buffer (12 mM Tris-HCl, 96 mM
glycine, 20% (v/v) methanol) and stacked on a nitrocellulose membrane pre-soaked in transfer
buffer, loaded into a transfer apparatus (BioRad), and submerged in transfer buffer. Transfer
was performed electrophoretically at 100 volts for 1 h 20 min with gentle stirring at 4°C.
Transferred membranes were washed in Tris-buffered saline (TBS; 10mM Tris-HCl, 150 mM
sodium chloride, pH 7.5) and incubated 1 h in blocking buffer (TBS with 5% (w/v) non-fat milk
powder). Buffer was poured off and the blocked membrane was washed in Tween-Tris buffered
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saline (TTBS; 20 mM Tris-HCl, 2 mM sodium chloride, 0.05% (v/v) Tween-20, pH 7.5), before
incubation in primary antibody solution (Mouse anti-His IgG stock, diluted 1000-fold in blocking
buffer) for 1 h. Antibody solution was removed, and the blotting membrane was washed twice
with 10 mL of TTBS, then incubated in secondary antibody solution (Rabbit-anti mouse IgGalkaline phosphatase conjugate stock diluted 2000-fold in blocking buffer). Antibody solution
was removed, and the blotting membrane was washed once with 15 mL of TTBS and once with
15 mL TBS. To visualize protein bands on the membrane, the blot was washed in BCIP (5bromo-4-chloro-3-indolyl phosphate) and NBT (nitro- blue tetrazolium chloride) solution for 10
min or until visible indole precipitate formed on the membrane. Blots were imaged on a BioRad
VersaDoc 4000 system with an f-stop of 11 and an exposure time of 3 sec.
Minimum inhibitory concentration (MIC) assay. E. coli AR3110 and E. coli AR3110 ΔbcsG were
grown for 16 h at 37°C in sterile, cation-adjusted Muller-Hinton media (0.3% (w/v) beef extract,
1.75% (w/v) casein acid hydrolysate, 0.15% (w/v) starch with the addition of 20 mg/L CaCl2 and
10 mg/L MgSO4) and the final OD600nm was adjusted to 0.500 +/- 0.01 with the addition or
removal of media. Polymyxin stocks were prepared by dissolving lyophilized peptides (Sigma) in
Muller-Hinton media at 64 µg/mL and serially diluting in fresh Muller-Hinton media to achieve
the concentrations tested (0-32 µg/mL). Eight replicates were tested per cell line, per peptide in
a 96-well microtiter plate (Sarstedt). Microtiter plates containing Muller-Hinton media were
inoculated with bacteria at a final OD600nm of 0.050 +/- 0.005 containing 200 µL of liquid media
and incubated at 30°C for 24 h. The OD600nm was read on a Cytation5 imaging microplate reader
(BioTek).
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4.5 X-ray crystallography and structural modelling
Seleno-L-methionine labelling. A minimal media kit for seleno-L-methionine labelling was
purchased from Molecular Dimensions. Minimal media was prepared by dissolving 21.6 g of the
medium base, containing sodium and potassium phosphate at pH 7.5 in 1 L of ddH2O and
sterilized in an autoclave at 121 °C for 30 min. The media was then supplemented immediately
prior to culture by dissolving 5.1 g of nutrient supplement (containing 4g D-glucose, trace
vitamins, and all L-amino acids, excluding L-methionine, at a final concentration of 40 µg/mL)
into 50mL of ddH2O and passing through a 0.45 µm syringe filter into sterile medium base.
Kanamycin and seleno-L-methionine, at concentrations of 50 µg/mL and 40 µg/mL, respectively,
were also supplemented aseptically prior to culture. The medium was inoculated with 50 mL of
starter culture from LB media grown 18 h at 37°C with 220 rpm shaking. Prior to inoculation,
the cells were separated from the media (i.e. containing unlabelled methionine) by
centrifugation at 4000 x g for 15 min and the media discarded. The cell pellet was washed in 40
mL of sterile ddH2O and was again separated from the water by centrifugation at 4000 x g for
15min. The ddH2O was discarded and the cell pellet was resuspended in minimal culture media.
Growth of protein crystals. Recombinant EcBcsGΔN was expressed and purified to homogeneity
as outlined above in sections 4.1 and 4.2 as above for selenomethionine labelled protein.
Prepared protein was concentrated in centrifugal filter units (30,000 Da MWCO; Pall
Corporation) to a concentration of 1 mM. Screening of crystallization conditions was performed
using a Crystal Gryphon instrument (Art Robins Technologies) using 1 µL volumes of protein in a
1:1 and 2:1 ratio with the mother liquor using the sitting drop method. The commercially
available MCSG suite (Crystalgen) was screened in its entirety for conditions permissible to
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crystal growth. After suitable condtions were identified, protein crystals were grown using the
hanging drop method in 24-well pregreased crystal plates (Crystalgen). Crystals were grown
against 0.1 M HEPES:NaOH, 20% (w/v) polyethylene glycol 4000, 10% (v/v) 2-propanol, pH 7.5
in 1:1, 2:1 and 1:2 ratios of protein solution (1 mM) over 500 µL reservoir volumes, and
incubated at 18°C in a Molecular Dimensions crystal growth incubator. Stored plates were
periodically observed by microscopy (Olympus SZX16 Stereomicroscope) for precipitation and
crystal formation. The EcBcsGΔN cosusbtrates p-NPPE, cellobiose, cellopentaose, and LysoPE
were dissolved in the crystallization condition at a concentration of 5 mM and was used to set
up as drops with EcBcsGΔN to attempt to crystallize the enzyme-cosubstrate complex.
X-ray diffraction analysis. Crystals were harvested from the crystal drop and subjected to
immersion for 5-20s in a cryoprotectant solution of 55% (v/v) 2-propanol, 10% (v/v)
poly(ethylene glycol) 4000, and 50 mM HEPES pH 7.5. The cryoprotected crystals were
submerged in liquid nitrogen until needed. Crystals were diffracted using synchrotron X-ray
light at the Canadian Light Source, Saksastoon, SK, Canada on beamline 08ID-1 and 08BM-1,
and at the Advanced Photon Source, Woodridge, IL, USA on beamline 17-ID-B. The presence of
Se in crystals was assessed with X-ray fluorescence by scanning an X-ray energy spectrum +/0.2 keV from the theoretical Se K edge (12.6 keV). For experimental phasing, single-wavelength
anomalous diffraction (SAD) experiments were performed by diffracting crystals at 12.656 keV,
an X-ray energy equal to the Se K edge and a complete 360° single-wavelength anomalous
diffraction (SAD) dataset was collected for initial structure solution, using 720 images of width
0.5°, an exposure time of 0.2 s per image, and a transmittance of 100%. Unlabelled crystals
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were diffracted with incident X-ray radiation with a wavelength of 1.0000 Å (12.398 keV) with
the same collection parameters.
Data processing and structure solution/refinement. Collected data were processed by
indexing, scaling and integrating frames in the XDS and/or Mosflm software suites92. Processed
SAD data was used to attempt structure solution using experimental phasing in the PHENIX
software package93. The native structure was solved using molecular replacementwith the
program PHASER93 using the Se-labelled structure as a search model94. Structural refinement
was performed using iterative rounds of automated refinement using PHENIX93 followed by
manual model building and refinement in Coot95. Refinement progress was monitored by
following the reduction (and convergence) of the Rwork and Rfree. Visualization of the model was
done in the PyMOL software package. The biological assembly of EcBcsGΔN was assessed using
the PDBePISA server96. Metal content was assessed with the CheckMyMetal server97.
Inductively coupled plasma – atomic emission spectroscopy. The metal content of EcBcsGΔN
was determined using ICP-AES. EcBcsGΔN was purified as described in section 4.2 above in the
absence of exogenous metals in the purification buffers. The analyzed samples were
concentrated to 1 mM and digested in 200μL of HNO3 by heating at 70°C for 1 h until all
EcBcsGΔN was dissolved. The sample was then passed through a 0.45 μm centrifugal filter and
diluted to 50 μM EcBcsGΔN and 2% v/v HNO3 with 18 megohm-cm-1 purity water and analyzed
for S, Mg, Co, Cu and Zn at two analytical wavelengths for each element (Mg: 285.213 and
279.077 nm; Zn 206.200 and 213.857 nm; Cu 327.393 and 324.752 nm; Co 228.616 and 238.892
nm) in a Perkin Elmer Optima 8000 ICP-AES. Prepared solutions of copper chloride, magnesium
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chloride, zinc sulfate, and 2% (v/v) HNO3 were used as analytical standards and the blank,
respectively.
Molecular phylogenetics. The sequence of putative pEtN transferase genes described by
Harper et al.63 were downloaded from the National Center for Biotechnology Information
(NCBI) protein sequence database. Multiple-sequence alignments were performed using the
constraint-based multiple alignment tool COBALT available at NCBI. For phylogenetic analysis,
the alignment data were visualized with FigTree 1.4.3 (http://tree.bio.ed.ac.uk/). Structural
homologues of EcBcsGΔN were queried using the DALI server98.

5. Results and Discussion
5.1 Expression and purification of EcBcsGΔN
Expression of EcBcsGΔN. High yields of soluble EcBcsGΔN were observable in the cell lysate of E.
coli BL21 (DE3) used as an expression host following culture and IPTG (1 mM) induction (Figure
7) for 16 h at 23°C. Protein yield following preliminary IMAC purification was routinely > 50
mg/L of culture at near homogeneity (Figure 7; Lane 3), and did not warrant further
optimization as yield and purity was sufficient for downstream applications. Purification to total

Figure 8: SDS-PAGE of a typical EcBcsGΔN purification. Lanes 1: Ladder, Lane 2: cell lysate, Lane 3: IMAC
elutions, Lane 4: IEC elutions.
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homogeneity at high yield (> 45 mg / L of culture) was possible by secondary purification using
either size exclusion chromatography or anion exchange chromatography (Figure 7; Lane 4).

5.2 Crystallization of EcBcsGΔN
Native EcBcsGΔN. Primary purification of EcBcsGΔN was performed by IMAC and secondary
purification was performed by SEC or IEC to total homogeneity and concentrated to 45 mg/mL
(1 mM) prior to the preparation of crystallization plates. Initial screening of the MCSG 1-4
Crystallization Suites identified two lead conditions permissible to EcBcsGΔN crystal growth:
MCSG4-G11 (0.1 M HEPES:NaOH pH 7.5, 20% (w/v) poly-(ethylene glycol) 4000, 10% (v/v) 2propanol) and MCSG4-F7 (0.2 M magnesium chloride, 0.1 M MES:NaOH pH 6.5, 25% (w/v) PEG
4000). Further expansion screening of these conditions by altering the pH or concentrations of
salts and precipitants failed to retain crystal growth and instead resulted in rapid EcBcsGΔN
precipitation. Crystals of native EcBcsGΔN appeared to form optimally in the MCSG4-G11

Figure 9: Representative EcBcsGΔN crystal size and morphology. Selenomethionine-labelled EcBcsGΔN
crystals grew with rhomboid morphology, ranging from approximately 150 x 50 μm (A) to 30 x 50 μm (B).
Native EcBcsGΔN crystals also grew with a rhomboid morphology, ranging from to 50 x 200 μm (C) to 50 x
100 μm (D).
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condition (0.1M HEPES:NaOH pH 7.5, 20% (w/v) poly-(ethylene glycol) 4000, 10% (v/v) 2propanol) when drops were prepared using EcBcsGΔN SEC buffer (20 mM Tris, 150 mM NaCl, 5
mM MgCl2, pH 7.5) as the solvent for recombinant protein. The presence of Mg2+ was critical for
crystal formation, as plates set up in the absence of Mg2+ did not display crystal growth
following 8 weeks of incubation at 22°C. In the presence of Mg2+, crystal growth could be
observed within 5-7 days of incubation as rod shaped crystals, ranging in size from
approximately 30 x 50 μm to 50 x 200 μm. Ideal crystal growth was observed after 28 days of
elapsed incubation, at which point cracking and damage to the crystalline lattice became
evident.
Seleno-L-methionine labelled EcBcsGΔN. Optimal crystal formation occurred for labelled
EcBcsGΔN similarly to native EcBcsGΔN following purification by IMAC and SEC. Crystals of
labelled enzyme grew readily in the MCSG4-G11 condition previously identified by highthroughput screening, and crystal growth also appeared to be dependent upon the presence of
Mg2+. Crystals appeared in the conditions tested after 7 days of incubation at 22°C and
appeared to cease growth after 24 days of incubation. Large, highly ordered rod-shaped crystals
were observed, similarly to crystals grown with native EcBcsGΔN, ranging in size from
approximately 50 x 100 μm to 100 x 250 μm (Figure 8).

5.3 The X-ray crystal structure of EcBcsGΔN
Model quality. The de novo structure of EcBcsGΔN was determined using the single-wavelength
anomalous diffraction (SAD) method with high-resolution (1.26 Å) anomalous scattering at the
selenium K edge (12.656 keV, 0.979647 Å) on crystals prepared with uniformly Lselenomethionine labelled EcBcsGΔN (herein EcBcsGΔN-Se). The diffraction experiment statistics
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are available in Table 4. The high-resolution diffraction data were reduced and included
reflections at a maximum resolution of 1.44 Å to ensure overall data quality as indicated by
correlation coefficients (e.g. CC1/2 > 0.8). Model building and refinement improved the Rwork and
Rfree from 0.212 and 0.229 to 0.197 and 0.212, respectively. Analysis of data suggested crystals
grew in space group P 21 21 21 with the model containing two copies of EcBcsGΔN in the
asymmetric unit, consistent with a Matthews coefficient of 2.09 and a solvent content of
approximately 40%. However, we observed no evidence that EcBcsGΔN may form a dimer in its
biological assembly during purification by size exclusion chromatography. The EcBcsGΔN model
presented excellent stereochemical parameters (Table 4) and covers almost the entirety of the
catalytic domain. The structure is complete at the C-terminus and truncates in an unstructured
loop immediately adjacent to the His6-tag at the N-terminal region of the soluble domain. One
copy of the protein in the asymmetric unit contains weak electron density about residues Ala484
and Ala382, and so these residues could not be reliably built into the model. In the second copy,
the fit of Ala484 and Ala382 to the density is satisfactory and the folding of EcBcsGΔN at these
residues can still be inferred from this model. No Ramachandran outliers are present, and only
16 residues (2.23%) lie outside the ideally preferred region and in the allowed regions. Only one
(0.32%) side chain rotamer outlier, Phe359, is present, and only in one copy of the molecule.
There are no obvious artefacts of crystallization, although small amounts of unmodelled density
about the active site contribute to the residual statistics.
The completed structure of EcBcsGΔN labelled with L-selenomethionine was used as a
molecular replacement search model to solve a dataset collected on an unlabelled native
EcBcsGΔN crystal. The data collection and refinement statistics for the unlabelled crystal are also
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Table 4: Diffraction data processing, refinement statistics, and model validation
Resolution range (Å)
Space group
Cell dimensions
a, b, c (Å)
α, β, γ (°)
X-ray energy (eV)
Total reflections
Unique reflections
Multiplicity
Average I/σ(I)
Completeness (%)
Anomalous completeness (%)
Rmerge
Rmeas
Rpim
CC1/2
CC*
Refinement statistics
Reflections used in refinement
Reflections used for R-free
Rwork
Rfree
CC(work)
CC(free)
Number of non-H atoms
Total
Macromolecules
Ligands
Solvent
Protein residues
RMS bond lengths (Å)
RMS bond angles (°)
Ramachandran favoured (% ; #)
Ramachandran allowed (% ; #)
Ramachandran outliers (% ; #)
Romater outliers (%)
Clashscore
Average B-factor
Total
Macromolecules
Metal ions
Solvent

EcBcsGΔN-Se
45.97 - 1.44 (1.491 - 1.44)
P 21 21 21

EcBcsGΔN
47.96 - 1.75 (1.813 - 1.75)
P 1 21 1

78.71, 94.58, 105.19
90, 90, 90
12656.0
1832824 (181077)
142127 (14051)
12.9 (12.9)
19.13 (2.64)
99.99 (99.99)
99.87
0.07407 (1.063)
0.7719 (1.108)
0.02148 (0.3069)
0.999 (0.773)
1 (0.934)

52.51, 76.92, 95.92
90, 90.578, 90
12398.4
520255 (43663)
74391 (6595)
7.0 (6.6)
28.56 (7.42)
96.64 (85.96)
N/A
0.0435 (0.2657)
0.04711 (0.2894)
0.01794 (0.1126)
0.999 (0.969)
1 (0.992)

142124 (14051)
7107 (703)
0.197 (0.272)
0.212 (0.311)
0.957 (0.828)
0.953 (0.760)

74372 (6577)
3719 (329)
0.161 (0.214)
0.198 (0.236)
0.965 (0.860)
0.951 (0.789)

6362
5657
3
702
725
0.007
1.24
97.77 ; 709
2.23 ; 16
0.00 ; 0
0.32 ; 1
1.62

6742
5706
3
1033
732
0.007
1.03
97.39 ; 713
1.79 ; 13
0.82 ; 6
0.32 ; 1
9.61

23.9
22.8
16.3
32.4

23.5
21.7
19.0
33.2

Values in parentheses correspond to the highest resolution shell. I/σ(I): intensity of a group of reflections divided by the
standard deviation of those reflections. Rmerge = ∑ |I(k) − <I>|/∑ I(k), where I(k) and <I> represent the diffraction intensity values
of the individual measurements and the corresponding mean values. The summation is over all unique measurements. Rwork = ∑
||Fobs|− k|Fcalc||/|Fobs|, where Fobs and Fcalc are the observed and calculated structure factors, respectively. Rfree is the sum
extended over a subset of reflections excluded from all stages of the refinement.
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listed in Table 4. A P 21 space group resolved to 1.75 Å with packing on an alternate face is
observed, although two copies are still present in the asymmetric unit. Refinement of the
native structure resulted in an improved Rfree and Rwork of 0.161 and 0.198, respectively. The
model also covers the entire C-terminal catalytic domain, with truncation at the N-terminus
near the His6 tag. Similar stereochemical parameters are observed in the native structure,
indicating a high-quality model of EcBcsGΔN. The same single rotamer outlier, Phe359 is present.
Six (0.82%) Ramachandran outliers are present, with thirteen (1.79%) residues lying outside the
preferred regions. No obvious artefacts of crystallization were observed in this model.
The overall fold of EcBcsGΔN. The crystal structure of EcBcsGΔN reveals a three-dimension al fold

bearing 15 α-helical and 13 β-sheet secondary structure elements (Figures 10 and 11). A 7stand β sheet is present at the core of the protein, flanked by five α helices. Both a large αhelical component and a small 3-strand antiparallel β-sheet are present at the N-terminal
region of the fold, presumably oriented towards the inner membrane in vivo, based on the
predicted orientation of the N-terminal region of EcBcsGΔN and its similarity to predicted
homologues. The structure truncates in a loop, presumably the linker between the catalytic
domain and the N-terminal transmembrane domain.
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Figure 10: Secondary structure topology cartoon of the overall fold of EcBcsGΔN. The overall topology
shows the (β/α)7 fold typical for the alkaline phosphatase superfamily. α-helices are coloured cyan and
β-sheets are coloured purple. The N- and C-terminus are denoted as N and C, respectively. Figure
generated with TOPDRAW.

5.4 EcBcsG is a member of the pEtN transferase family.
Structural homology. Our results show that the soluble, periplasmic domain of BcsG
folds in a globular structure that is typical of the alkaline phosphatase superfamily. A structural
homology search on the Dali server98 showed EcBcsGΔN belongs to a family of sulfatases,
lipotechoic acid synthetases, and phosphatidyl-ethanolamine transferases. Among the highest
scoring results are EptC from Campylobacter jejuni (CjEptC, PDB ID 4TN0), EptA from Neisseria
meningitidis (NmEptA, PDB ID 4KAY), and the mobile colistin resistance factor 1 MCR-1 (PDB ID
5K4P) with z-scores of 20.4, 20.2, 20.4 and 20.2, respectively. A review of the literature reveals
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all three of these top structural homologues function as phosphoethanolmine (pEtN)
transferases, using membrane phosphatidyl-ethanolamine as donor and decorating lipid A-Kdo2
with phosphoethanolamine64,65,72,77 and belong to a family of related enzymes that have been
referred to as the pEtN transferase family73.
Using PyMOL, a Cα structural superposition of EcBcsGΔN with these structures resulted in
an average alpha-carbon r.m.s.d. of 2.953 Å across 173 equivalent Cα atoms (Fig. 12). Among
the highest regions of conservation in folding architecture are four loops adjacent to the core βsheet of all structures tested. These loops contribute residues to the active site of the pEtN
transferase family and suggest that the active site of EcBcsG may also be comprised of these
folds. A subsequent amino acid sequence alignment of EcBcsGΔN, MCR-1, CjEptC, and NmEptA
revealed several blocks of conserved residues among these structures, although the alignment
was generally poor due to low sequence identity of EcBcsG and structural features had to be

Figure 11: The overall fold of EcBcsGΔN. The structure is rendered as an α-carbon backbone trace with
secondary structure element cartoons. α-helices are coloured cyan, β-sheets are coloured purple, and
loops are coloured salmon. The solvent-accessible surface is rendered gray with a solvent radius of 0.5
nm. Rendered using PyMOL.
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Figure 12: A structural superposition of EcBcsGΔN with the homologous phosphoethanolamine
transferases MCR-1, CjEptC and NmEptA. Significant folding similarity is observed, particularly across
four loops that line the active site pocket of the EcBcsGΔN homologues. The amino acid sequence
alignment of these loops is shown in blocks 1-4 (inset). Residues highlighted in red are involved in metal
binding or catalysis.

manually aligned. The complete sequence alignment is available in Appendix 1 – Figure A8. Not
surprisingly, these blocks of conservation are contained within the structurally similar loops of
these enzymes (Fig. 12). However, some residues that contribute to the active site of NmEptA,
CjEptC, and MCR-1 do not appear conserved in EcBcsGΔN, and suggest divergent evolution of
EcBcsG from these structures, likely owing to their activity on lipid A, a vastly different
substrate. Metal coordination in the active site of the MCR-1 like family is achieved by aspartic
acid, glutamic acid, histidine, and a threonine residue – observed as phosphothreonine in the
structures of MCR-1, CjEptC and NmEptA. Equivalents to the glutamic acid and histidine of
other known pEtN transferases are present in EcBcsGΔN as residues Glu442 and His443. Cys243 and
Ser278 in EcBcsGΔN are both positioned near these residues and may instead serve as equivalent
to the metal-binding functions of the glutamic acid and threonine of the other pEtN
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Figure 13: The conserved pEtN transferase active site. The catalytic fold is comprised of a conserved HisAsp-Glu Zn2+-binding triad, a catalytic phospho-threonine nucleophile, and conserved histidine, as
demonstrated from representative structures of lipid A pEtN transferases (B). EcBcsG (A) contains an
unusual active site for the family, shaped by a Cys in place of the Zn2+ binding Glu, and a serine catalytic
nucleophile.

transferases, and the hydroxyl of Ser278 may also be phosphorylated in a fashion analogous to
CjEptC and NmEptA. Additionally, proton abstraction from the catalytic threonine is proposed
to be accomplished by the metal-adjacent glutamic acid in the pEtN transferse family72.
However, despite these amino acid equivalents that may plausibly serve catalytic roles in
EcBcsG, the mechanism is unclear from the structure of the holoenzyme alone.
Molecular Phylogenetics. Harper et al. reconstructed the molecular phylogeny of known and
predicted pEtN transferases and showed the family contains distinct subfamilies, clustered
based upon the substrate to which the enzyme transfers the pEtN group63. Known substrates
for which pEtN transferases have specificity include the 6’OH of the lipopolysaccharide inner
core Heptose II99, the 3’ OH of lipopolysaccharide inner core Heptose II99, various positions of
the lipopolysaccharide outer core Gal63, the 1’ phosphate of lipid A72,77, various periplasmic or
extracellular proteins63,74, and various periplasmic glycans, including the osmoregulated
periplasmic glucan (OPG) in E. coli100 and the periplasmic protein N-linked glycan in C. jejuni101.
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To date, all available structures of the pEtN transferase family are limited to those belonging to
the subfamily specific for the 1’ phosphate of lipid A. Furthermore, Stogios and colleagues73
constructed a sequence-based phylogenetic analysis of the enzymes belonging to this subfamily
specific for the 1’ phosphate of lipid A and found that the subfamily further contains sequence
dissimilarity with at least four major clades73. Although the membership of EcBcsG to the pEtN
transferase family is apparent from its structural homology to the lipid A transferases, its
placement within the family is unclear due to the limited number of available structures, of
which all belong to the subfamily with substrate specificity for lipid A. To address the
relationship of EcBcsG to the other pEtN transferase family members, a sequence-based phylogenetic analysis was performed with a sequence-based alignment using COBALT and visualized
as a maximum-likelihood tree using FigTree (Fig. 14). The phylogenetic analysis was based on
the known and predicted pEtN transferase family members compiled by Harper et al.63 using
sequence data available from repositories and was updated to include EcBcsG. The EcBcsG
sequence aligned poorly to other known and predicted pEtN transferases and clustered
independently, which was not surprising given the divergence of residues in EcBcsG that are
otherwise strictly conserved in the pEtN transferase family. The phylogenetic analysis suggests
that BcsG belongs to a novel subfamily of phosphoethanolamine transferases which cluster
near to pEtN transferases with specificity for the C6 hydroxyl of lipopolysaccahride Heptose II.
This is interesting given that the proposed regioselectivity of EcBcsG is for the C6 hydroxyl of a
hexose.
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Figure 14: Phylogenetic analysis of representative known and predicted pEtN transferases based on
Harper et al. Shaded clusters represent subfamilies that share substrate specificity as follows; pink,
transferases specific for 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) residues of lipopolysaccharide;
green, transferases specific for the C6 OH of Heptose II residues of lipopolysaccharide; gray, transferases
specific for the C3 OH of Heptose II residues of lipopolysaccharide; yellow, transferases specific for the
outer core Gal residues of lipopolysaccharide; blue, transferases specific for the 1’ phosphate of lipid A.
Bacterial species names are listed in sequence annotations of the tree as follows; Acti.p, Actinobacillus
pleuropneumoniae; Aero.s, Aeromonas salmonicida; Aggr.a, Aggregatibacter actinomycetemcomitans;
Bp, Bordetella pertussis; Cj, Campylobacter jejuni; Ec, Escherichia coli; Hd, Haemophilus ducreyi;
Hf, Haemophilus felis; Hh, Haemophilus haemolyticus; Hi, Haemophilus influenzae; Hp, Helicobacter pylori;
Mh, Mannheimia haemolytica; Ng, Neisseria gonorrhoeae; Nm, Neisseria meningitidis; Pm, Pasteurella
multocida; Sf, Shigella flexneri; Shew.p, Shewanella putrefaciens; ST, Salmonella
enterica subsp. enterica serovar Typhimurium; Vc, Vibrio cholerae; Vh, Vibrio harveyi; Vp, Vibrio
parahaemolyticus. Generated with FigTree.
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Metal-binding sites. Metal-dependency is typical for the alkaline phosphatase superfamily,
although the physiological metal and the coordination environment of superfamily members
varies widely102. A survey of structurally resolved members of the pEtN transferase family
demonstrates dependency on Mg2+, Zn2+, or a combination of these. Because of the overall
EcBcsGΔN fold typical of metal-dependent members of the alkaline phosphatase superfamily,
similarity to the pEtN transferase family, and the apparent stabilizing effect of including Mg2+ in
purification and crystallization conditions, the structure of EcBcsGΔN was surveyed for sites in
which Mg2+ might bind. In the putative EcBcsGΔN active site, the top of helix 6 (residues 278286) and three loops protruding from the top of β strands 18, 16, and 2 fold into a solventaccessible pocket. The side chains of Cys243, Ser244, Ser278, His396, Glu442, and His443 face in
towards this pocket (Fig. 14). A large peak detectable > 7 σ in the Fo-FC map was calculated in
this pocket and was not attributable to the EcBcsGΔN macromolecule, observed adjacent the
side chains of Cys243 Ser278, Glu442, and His443 in a tetrahedral geometry, suggesting that a ligand

Figure 15: The Fo-Fc map contoured at 7 σ about the putative active site of EcBcsGΔN. A large positive
difference peak in the Fo-Fc map suggests a metal ligand is bound here.
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is bound here (Figure 15). Surprisingly, placement of either a Mg2+ ion or a water molecule into
this electron density refined poorly and suggested a poor fit to the diffraction data. However, a
second site at which electron density suggests another ligand-binding site is observed
elsewhere in the resolved structure of EcBcsGΔN. A second large Fo-Fc peak was calculated
adjacent to the amide nitrogen of Thr478 and Asn483, and the side chain of Asp481 (Figure 16).
This second ligand site is also coordinated by three highly ordered water molecules in an
octahedral arrangement. Occupancy of this site with Mg2+ (present from the crystallization
conditions) into this density refined optimally and suggested a good fit of this ligand with the Xray diffraction data. In the second copy of EcBcsGΔN present in the asymmetric unit, however,
this electron density was not observed and the local folding near this site differs from the
ligand-bound state. These observations suggested that Mg2+ likely plays a role in EcBcsGΔN
folding in this local region and accounted for the stabilizing effect of magnesium salts during
purification and crystallization of EcBcsGΔN.

Figure 16: The Fo-Fc map contoured at 7 σ about the secondary metal-binding site. A strong calculated
electron density peak is observed bound to D481, N483 and T478, likely a Mg2+ ion.
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To further investigate the identity of the ligands at these two binding sites, the structure
of EcBcsGΔN was uploaded to the CheckMyMetal server97 (https://csgid.org/metal_sites). The
results suggest the ligand environment of the secondary ligand site (D481/483/478) is typical of
Mg2+ binding sites for all parameters tested and provides further evidence that the identity of
the secondary site ligand is in fact Mg2+. This analysis also confirmed skepticism that the active
site (C243/S278/E442/H443) ligand may also be Mg2+, as tetrahedral geometry is not typical for
Mg2+ ligands and Mg2+ was also a poor fit to the local B factor and bond-valence parameters of
the crystal in this region (Fig. 17). Instead, the results suggested a ligand environment in the
active site more typical of Co2+, Cu2+, or Zn2+, although no clear preference was observed.
Further refinement of the resolved EcBcsGΔN structure with all three of these metal ions as
ligands in active site resulted in an equally good fit to the experimental data and did not further
suggest the identity of the physiological ligand. To unambiguously identify the ligand in the
putative active site, EcBcsGΔN was purified in the absence of exogenous metal ions using buffers
prepared with 18 megaohm cm-1 water and was digested in HNO3 for analysis by ICP-AES. The
EcBcsGΔN elemental spectra for Zn2+, Cu2+, Co2+ and Mg2+ unambiguously confirm the identity of
the ligands observed by X-ray diffraction (Figure 18). A strong analytical signal, > 40-fold above

Figure 17: Output from the CheckMyMetal server. Site ID 1 is the active site and site ID 3 is the
secondary site.
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Figure 18: ICP-AES emission spectra at analytical wavelengths for Mg, Zn, Cu and Co. A strong emission
singal was observed for Mg and Zn, but not for Cu or Co. Emission of the analytical standards suggest 1
equivalent of Mg and Zn per polypeptide chain.

the blank for Mg2+ and > 90-fold for Zn2+ was observed, while weak signal intensities for Cu2+
and Co2+ were observed, approximately 1.5-fold and 4-fold above the blank, respectively.
Further analysis of analytical standards of 10 μM Zn2+ and 15 μM Cu2+ further confirm that the
Cu2+ and Co2+ levels represent negligible quantities, while Zn2+ and Mg2+ are present in sufficient
quantities to conclude that they must comprise the observed ligands in the structure of
EcBcsGΔN. Concurrently, crystals of EcBcsGΔN were analyzed by X-ray fluorescence (XRF)
spectroscopy near the K edge for Mg (1.3050 keV), Zn (9.6586 keV), Cu (8.9789 keV), and Co
(7.7089 keV) and confirmed the presence of Mg and Zn in EcBcsGΔN crystals. Final refinement of
the structure of EcBcsGΔN was completed with these ligand sites occupied by Zn2+ and Mg2+.
Internal disulfide bond. While the number of total disulfide bonds identified varies from
three (CjEptC and MCR-1) to five (NmEptA) in the pEtN transferase structures examined here,
only a single conserved disulfide bond, separated by 10 amino acids, is shared by all three of
these structures65,72,77. This disulfide bond is shaped by the conserved cysteine pairs Cys262Cys272 in CjEptC, Cys281-Cys291 in MCR-1, and Cys276-Cys286 in NmEptA (Figure 18) 65,72,77.
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The conserved disulfide bond directly fixes the helical secondary structural elements of
NmEptA, CjEptC and MCR-1, which contribute the respective catalytic threonine nucleophiles,
to the loops immediately N-terminal of each helix 65,72,77. These conserved disulfides thus orient
the catalytic nucleophiles in close proximity to the Zn2+ ion present at the respective catalytic
centers. Recently, the structure of EcEptC (PDB ID 6A83) was reported to have an overall similar
fold and share structural similarity with the pEtN transferase family66. However, EcEptC did not
confer polymyxin resistance in vivo despite sharing the conserved active site architecture and
catalytic Zn2+ binding discussed here66. Instead, Zhao et al.66 proposed that the absence of Cys
pairs forming disulfides in EcEptC was responsible for the lack of observed activity, and showed
that disruption of Cys pairs in MCR-1 or CjEptC also abrogated polymyxin resistance when
expressed in E. coli C43 to levels observed with expression of EcEptC66.
To understand the importance of disulfide bond presence in EcBcsG, the
structure was examined for the presence of the conserved disulfide bond. The equivalent
amino acids to the conserved cysteine pairs from CjEptC, NmEptA and MCR-1 described above
are observed as Ala274 and Arg284 in EcBcsGΔN. Instead, an unambiguous disulfide bond was
observed in both the native and Se structures of EcBcsGΔN between the cysteine pair Cys290Cys306, spaced instead by 16 amino acids (Figure 19). This unusual disulfide bond in EcBcsG
appears to serve the same function as the conserved pEtN transferase disulfide bond, despite
being structurally distinct. Instead of fixing the helix presenting the catalytic nucleophile to a
loop directly N-terminal to it, the EcBcsG disulfide instead links the loop immediately C-terminal
of the equivalent helix with a neighbouring helical element packed against the central betasheet fold. This novel disulfide retains the conserved structural features related to their
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proposed function; orienting the catalytic EcBcsG nucleophile, Ser278, in proximity to the
catalytic Zn2+ of the EcBcsGΔN active site in an analogous fashion to CjEptC, NmEptA and MCR-1.

Figure 19: The pEtN transferase disulfide bond. A conserved, disulfide bonded cysteine pair in CjEptC
(green), MCR-1 (magenta), and NmEptA (orange) fixes the helix presenting the catalytic threonine
adjacent to the catalytic Zn2+ at the active site and is important for activity. In EcBcsGΔN (cyan), a similar
disulfide is observed, although not at the conserved location. Figure rendered in PyMOL.

Polymyxin Susceptibility Assay. Several members of the pEtN transferase family have been
described to transfer pEtN to both lipid A and other secondary substrates, including the C. jejuni
periplasmic N-linked glycan101, flagellins77, pilins15,74, and likely other diverse periplasmic
targets. To assess if EcBcsG retains activity on lipid A in vivo, the susceptibility of E. coli AR3110
and E. coli AR3110 ΔbcsG to the antimicrobial peptides polymyxin E (colistin) and polymyxin B
were assessed using a minimum inhibitory concentration (MIC) assay. The observed MIC of
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colistin was 2 μg/mL in both AR3110 and E. coli AR3110 ΔbcsG, in agreement with colistinsusceptible E. coli isolates that do not possess intrinsic or acquired colistin resistance (Figure 20)
103

. The polymyxin B MIC was observed to be 4 μg/mL for E. coli AR3110 and 8 μg/mL for E. coli

AR3110 ΔbcsG. Furthermore, visible quantities of biofilm were present in the microtiter plate at
the time of analysis, confirming the conditions of the assay were biofilm-permissive. Our
findings did not support the hypothesis that EcBcsG retains activity on lipid A in vivo to confer
intrinsic polymyxin resistance, since EcBcsG expression was not correlated with colistin MIC.

Figure 20: Colistin and polymyxin B minimum inhibitory concentration assay. Growth under biofilmpermissive conditions did not induce intrinsic polymyxin reistance in E. coli AR3110, nor did nonpolar
deletion of bcsG in E. coli AR3110 induce polymyxin susceptibility.

5.4 Functional complementation of EcBcsG
Pellicle assay. The colony morphotype of E. coli K-12 and S. enterica UMR1, and nonpolar bcsG
chromosomal mutant derivatives thereof, have been described previously as a reporter for
BcsG activity when grown on semisolid media containing Congo Red104. However, bcsG deletion
mutants were observed to produce cellulose and, thus, retain a red, dry and rough morphotype
using this assay. As a result, the colony morphotype of E. coli bcsG deletion strains producing
unmodified cellulose was indistinguishable from that of the wild-type E. coli strains producing
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pEtN cellulose. To detect the phenotypic consequences of loss of bcsG function, a robust assay
was developed to distinguish the functional contribution of bcsG and, thus, pEtN cellulose to
the E. coli K-12 biofilm phenotype. Our results recapitulate those by Thongsomboon et al.32 and
demonstrate that the pEtN modification conferred by EcBcsG activity on cellulose is essential
for the E. coli AR3110 extracellular matrix assembly and architecture. The wild-type cellulose
producing strain E. coli AR3110 produced a rigid pellicle that formed a cohesive, tissue-like layer
when grown in salt-free LB broth that adhered to solid surfaces and was resistant to mechanical
stress (Figure 21). The nonpolar chromosomal bcsG mutant in the E. coli AR3110 background
(AR3110 ΔbcsG) produced a similar pellicle morphotype, although the biofilm did not display
the same cohesive properties and was completely disrupted upon subjection to mechanical
stress. Functional complementation of the AR3110 ΔbcsG cell line with the pET28a-encoded,
full-length recombinant bcsG construct restored the rigid, self-assembling properties of the
extracellular matrix, while complementation with the C-terminal catalytic domain or the vector
alone failed to restore these properties and their biofilms were mechanically disrupted with
ease, demonstrating that full-length EcBcsG is both necessary and sufficient for pEtN cellulose
and, thus, the rigid pellicle phenotype observed in this experiment.

Figure 21: The pEtN cellulose pellicle assay. The rigid pellicle phenotype of E. coli AR3110 is lost upon
deletion of bcsG and is rescued only by complementation with pBcsG, but not pBcsGΔN or the pET28a
plasmid. Pellicles were stained in 0.01% (w/v) Congo Red following isolation from cultures and visualized
with a BioRad VersaDoc 4000.
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Crystal Violet Adherence Assay. A semi-quantitative analysis of the adherence potential of
these phenotypes was performed using a crystal violet static biofilm assay, and the adherence
potential appeared to follow the pellicle phenotype assayed above (Figure 21). Comparison of
the AR3110 cell line to its ΔbcsG derivative suggested that loss of bcsG results in the loss of
adherence potential by the biofilm, easily removed from the growth surface by gentle washing
in phosphate buffered saline. The AR3110 cell line demonstrated > 4-fold higher crystal violet
staining than the nonpolar bcsG mutant, restored by functional complementation with bcsG,
but not bcsGΔN or the vector alone.

Figure 22: Crystal violet adherence of pellicle biofilms. The adherence potential of E. coli AR3110 is lost
upon deletion of bcsG and was rescued only by complementation with pBcsG, but not pBcsGΔN or the
pET28a plasmid. Asterisks denote significantly different groups (p < 0.05, Welch test)

Site-Directed Mutants. To map the active site of EcBcsG and elucidate the function of key
residues identified in its structure, site-directed mutants of the full-length recombinant EcBcsG
were generated and their sufficiency to rescue the fragile pellicle phenotype of the E. coli
AR3110 ΔbcsG cell line were assessed using the pellicle (Figure 23) and static crystal violet
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assays (Figure 2r). Protein variants of EcBcsG, supplemented to E. coli AR3110 ΔbcsG in trans,
containing single alanine substitutions in amino acids Cys243, Ser278, Glu442, His443, His396, and
Tyr277 failed to functionally complement the chromosomal bcsG deletion, and resulted in the
growth of fragile pellicle that was sensitive to mechanical disruption (Fig. 22). A Tyr277Phe
protein variant was also constructed by mutagenesis of pBcsG to assess if Tyr277 is involved in
substrate accommodation of cellulose, noted as a possibility based on its position in the crystal
structure. To our surprise, the Tyr277Phe mutation also did not rescue the fragile pellicle
phenotype of E. coli AR3110 ΔbcsG, suggesting that the tyrosine hydroxyl may instead be
involved in forming polar contacts with substrate, rather than through ring-stacking
interactions. Additionally, the Phe329Ala protein variant rescued the fragile pellicle phenotype of
E. coli AR3110 ΔbcsG, also suggesting that ring-stacking interactions by both aromatic residues
lining the predicted active-site pocket do not function in substrate-binding or catalysis by
EcBcsG.
To further investigate the hypothesis that the observed disulfide bond is important for
catalytic activity of EcBcsG, a disulfide-deficient variant, EcBcsG C290A C306A, was constructed
and assessed for its activity in vivo using the functional complementation experiment. The

Figure 23: Pellicle assay data for EcBcsG amino acid variants. Alanine substitutions of Cys243, Ser278,
Glu442, His443, or Tyr277 fail to rescue the fragile pellicle phenotype, while an alanine substitution in Phe329
did rescue the fragile pellicle phenotype. A further Tyr277Phe substitution failed to rescue the fragile
pellicle phenotype.
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Figure 24: Crystal violet assay data for EcBcsG amino acid variants. Alanine substitutions of Cys243, Ser278,
Glu442, His443, or Tyr277 fail to rescue the adherence potential of E. coli AR3110 ΔbcsG, while an alanine
substitution in Phe329 did rescue the adherence potential. A further Tyr277Phe substitution failed to
rescue the adherence potential.

results demonstrated that the EcBcsG C290A C306A did not functionally complement E. coli
AR3110 ΔbcsG and failed to rescue the fragile pellicle phenotype. This data suggests that the
disulfide is indispensable for catalytic activity in vivo, and disruption of this disulfide results in a
phenotype indistinguishable from EcBcsG variants with disruptions in the essential catalytic
architecture. This indispensability of the disulfide bond corroborates the role of this disulfide as
a mimic of the conserved disulfide in the other pEtN transferases discussed here despite its
alternate position in the structure.

CHARACTERIZING BcsG

70

Mutant Expression. A Western immunoblot of prepared E. coli AR3110 ΔbcsG cell lysates (30 μg
total protein/well) supplemented with wild-type and variant pBcsG demonstrated invariable
expression of bcsG and its variants from the pBcsG plasmid in trans at low, but detectable,
levels indicating that differences in pellicle phenotype of these cell lines are attributable to
differences in their amino acid composition and not their differential expression (Figure 25).

Figure 25: Western immunoblot against the recombinant His-tag of cell lysates from the functional
complementation experiments. Uniform expression is observed across the wild-type and amino acid
variants.

5.5 Functional bioassay
Synthesis of p-NPPE. Repeated screening and analysis of various commercially available
substrate analogs failed to detect enzymatic product from EcBcsGΔN . Substrates tested include
O-phosphorylethanolamine (Sigma), 1-myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine
(14:0 LysoPE, Avanti), deoxyguanosine triphosphate, deoxycytosine triphosphate,
deoxyadenosine triphosphate, deoxycytosine triphosphate, and various cellulose analogs, such
as Avicel® PH-101, hydroxyethylcellulose, and carboxymethyl cellulose. A review of the
literature revealed that at least one other member of the pEtN transferase family, MCR-1, was
capable of using the synthetic compound para-nitrophenyl phosphoethanolamine (p-NPPE),
and that its synthesis was possible from commercially available starting materials. We
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attempted the synthesis of p-NPPE as described by Dimitrijevic and colleagues105 and
successfully isolated the synthetic product, p-NPPE trifluoroacetate, as a fine white crystalline
powder through the work of colleague (Lana Hiscock) in Dr. Maly’s laboratory (Wilfrid Laurier
University). The organic product was structurally analyzed by 1H, 13C, 19F and 31P NMR
spectroscopy and IR spectroscopy (Appendix 1). Quality control of p-NPPE was prepared by
dissolving the p-NPPE trifluoroacetate in 10 M NaOH and performing an absorbance spectral
scan and the λmax was found to be 414 nm (Appendix 1). This value was used for all further
functional bioassay experiments utilizing p-NPPE. A standard curve of base-hydrolyzed p-NPPE
was performed and compared to an analytical reference standard of paranitrophenolate
(Sigma). No significant difference was detected between the reference standard and the pNPPE we prepared (Appendix 1), and so it was deemed suitable for downstream analysis with
EcBcsGΔN.
Activity of EcBcsGΔN. To test EcBcsGΔN activity, the enzyme was overloaded with substrate at
levels described by Wanty and colleagues for MCR-1 (i.e. 5 mM)65. Incubation of EcBcsGΔN with
the chromogenic substrate p-NPPE resulted in the release of the para-nitrophenolate ion giving
a strong absorbance at 414 nm at a rate significantly higher than an enzyme-free control (t-test,
p < 0.05, Figure 26). To test if EcBcsGΔN was capable of transferase activity in vitro, an identical
reaction to the one described above was performed with the addition of 1 mM of either Dglucose (Sigma), β-D-cellobiose, β-D-cellotriose, β-D-cellotetraose, β-D-cellopentaose, or β-Dcellohexaose (Megazyme). Under conditions containing 1 mM of β-D-cellotetraose, β-Dcellopentaose, or β-D-cellohexaose, a significant increase in the rate of formation of the paranitrophenolate ion was observed in a length-dependent fashion (Figure 27). To then test the

CHARACTERIZING BcsG

72

substrate specificity of EcBcsGΔN for cellulose, further transferase assays were performed with
the addition 1 mM β-D-chitobiose, β-D-chitotriose, β-D-chitotetraose, β-D-chitopentaose, or βD-chitohexaose. No significant increase in the rate of formation of the para-nitrophenolate ion

was observed in the presence of any of these chitooligosaccharides as compared to an
acceptor-free control reaction (Figure 27).

Figure 27: EcBcsGΔN liberates para-nitrophenolate from p-NPPE. A significantly increase in the rate of pNPPE cleavage and para-nitrophenolate formation was observed in the presence of 50 μM EcBcsGΔN.

Figure 26: Phosphoethanolamine transferase assay. The rate of para-nitrophenolate formation in the
presence of EcBcsGΔN was increased in the presence of celloligosaccharides 4 residues or longer, and in a
length-dependent fashion (left). No such increase was observed with chitooligosaccharides (right).
Letters denote statistically significant groupings (ANOVA, p > 0.0001).
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In an effort to detect the enzymatic product, both the reaction condition containing
cellopentaose and an enzyme-free control were repeated for a 24 h duration. The resulting
reaction mixtures were spotted on a silica plate for analysis by thin-layer chromatography.
Following separation, staining of the silica matrix revealed a shift in the retention of the
carbohydrate component of the reaction mixture following treatment with EcBcsGΔN (Fig. 28).

Figure 28: Thin-layer chromatography of the EcBcsGΔN product. Cellopentaose (1 mM) in the presence of
p-NPPE (5 mM) has a high retention time in the nonpolar mobile phase (left) that is reduced by
treatment with 50 μM EcBcsGΔN (right). TLC plate was stained in a 3% (w/v) α-napthol dissolved in 25:3:2
methanol:water:sulfuric acid solution.

To confirm the increase in the rate of turnover of p-NPPE was the result of transferase activity,
the reaction products from the sample containing cellopentaose were then separated and
analyzed by LC-MS to confirm the transfer of the pEtN group. Along with unreacted p-NPPE
([C8H12NO6P]+H+, m/z 263.1614) and cellopentaose ([C30H52O26]+H+, m/z 829.2814), there was
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observed a new species with a novel m/z corresponding to the expected molecular weight of
the monosubstituted pentamer ([C32H58NO29P]+H+, m/z 952.2892: Fig. 29). Such a species was
absent in an enzyme-free control, which instead contained only the m/z species corresponding
to the starting materials.

Figure 29: The EcBcsGΔN enzymatic product mass spectra. Two nominal m/z species corresponding to
mono-pEtN substituted cellopentaose were observed in the presence of EcBcsGΔN.

Rate kinetics. To measure the apparent kinetic parameters of EcBcsGΔN using the in vitro assay
described here, the apparent initial enzymatic rate was measured at varying concentrations of
p-NPPE using a fixed concentration of 1 mM cellopentaose, and vice versa. Variation of p-NPPE
from 0-10 mM and curve fitting (Fig. 30) of the subsequent initial rates as a function of
substrate concentration resulted in an apparent Km of 1.171 ± 0.267 mM, maximal rate (Vmax) of
5.728 ± 0.345 nmol min-1 mg-1, and kcat of 1.91 x 10-6 ± 1.15 x 10-7 s-1. The derived catalytic
efficiency kcat/Km was 1.63 x 10-3 ± 3.84 x 10-4 M-1 s-1. The experiment was repeated at a fixed
concentration of 5 mM p-NPPE (approximately 3x the Km) and cellopentaose concentration
varying from 0 to 2.5 mM cellopentaose in 0.25 mM increments. Curve fitting of the measured
initial rates as a function of substrate concentration resulted in an apparent Km of 1.435 ± 0.632
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mM, Vmax of 12.27 ± 2.67 nmol min-1 mg-1, and kcat of 4.09 x 10-6 ± 8.86 x 10-7. The derived
catalytic efficiency kcat/Km was then 2.4 x 10-3 ± 7.00 x 10-4 M-1 s-1. However, this model did not
account for considerable rate of esterase activity observed of EcBcsGΔN (i.e. transfer to water
rather than cellopentaose). To better model the kinetic behaviour of EcBcsGΔN under varied
acceptor cosubstrate concentrations, the initial rates were corrected to discount the
contribution of esterase activity against p-NPPE and the resulting initial rates were fit to a
sigmoidal model (Figure 30). The model parameters were in good agreement with the p-NPPE
kinetic values, with a calculated K1/2 of 1.701 ± 0.332, Vmax of 8.219 ± 1.435 nmol min-1 mg-1, and
Hill slope of 1.877 ± 0.371. The kinetic parameters are summarized below in Table 5.

Figure 30: Curve fitting of EcBcsGΔN kinetic parameters. The specific EcBcsGΔN activity with varying p-NPPE
(left) or cellopentaose (right) at a fixed concentration of cosubstrate were fit to Michaelis-Menten and
sigmoidal models, respectively.

Table 5: Measured kinetic parameters of EcBcsGΔN
Km/K1/2 (mM) Vmax (nmol min-1 mg-1)
p-NPPE
1.171 ± 0.267
5.728 ± 0.345

kcat (s-1)
1.91 x 10-6 ± 1.15 x 10-7

Cellopentaose 1.701 ± 0.332
8.219 ± 1.435
*4.09 x 10-6 ± 8.86 x 10-7
* Based on ambiguous fitting to Michaelis-Menten model

kcat/Km (M-1 s-1)
1.63 x 10-3 ± 3.84 x 10-4
*2.4 x 10-3 ± 7.00 x 10-4
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Amino Acid Replacements. To assess the catalytic consequences of amino acid substitutions
within the EcBcsG active site, a library of amino acid EcBcsGΔN variants was constructed with
substitutions of active site residues we observed to be essential for catalytic activity in vivo. All
of the constructs used in this study, C243A, Y277F, S278A, H396A, E442A, and H443A were
generated using site-directed mutagenesis of pBcsGΔN. Each of these recombinant proteins
expressed in E. coli BL21 transformants with observed yields similar to that of wild-type
EcBcsGΔN. These variant proteins were purified to apparent homogeneity using the protocol
described previously, with no modifications (Fig. 31). Care was taken to use new
chromatography media for the purification of each respective enzyme to prevent enzyme carryover and cross-contamination of assay data.

Figure 31: SDS-PAGE of purified EcBcsGΔN amino acid variants. All amino acid variants tested expressed
and purified to near homogeneity in a fashion similar to wild-type EcBcsGΔN. Each gel shows a major
band representing recombinant and amino-acid substituted EcBcsGΔN at 45.5 kDa.

As expected, replacement of the catalytic nucleophile Ser278 resulted in a loss of any
detectable activity. The observed rates of both esterase and transferase activity of the Ser278
Ala replacement were not different from an enzyme free control (e.g. 1.96 ± 0.05 nmol min-1
mg-1, 1.93 ± 0.13 nmol min-1 mg-1, and 1.94 ± 0.06 for the control, esterase, and transferase
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activity, respectively; Fig. 32). The next greatest observed loss of activity was measured for the
replacement of Glu442 with Ala, also with an esterase activity indistinguishable from an enzymefree control (e.g. 1.96 ± 0.07 nmol min-1 mg-1; Figure 31). Only 2.3% residual transferase activity
for the Glu442 variant could be detected in the presence of β-D-cellopentaose.

Figure 32: Measured specific activities of EcBcsGΔN amino acid variants both in the absence of
cellopentaose (esterase) and in the presence (transferase). wt = wild-type EcBcsGΔN.

Similarly to Glu442, replacement of Cys243 with Ala resulted in residual specific activities
of 4.7% (esterase) and 2.4% (transferase), consistent with the essential Zn2+-binding roles of
these residues (Fig. 32). The His443 substitution also demonstrated reduced specific activities,
although to a lesser degree, representing 38.5% residual esterase and 10.4% residual
transferase activity. Furthermore, replacement of His396 with Ala produced an enzyme with a
residual esterase activity of 16.6% and a residual transferase activity of 7.0%, consistent with
the observation that this histidine is highly conserved and catalytically important in other pEtN
transferases.
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Replacement of Tyr277 with Phe produced an enzyme variant with greater esterase
activity and 84% residual transferase activity compared to wild-type EcBcsGΔN (Fig. 32). This
observation did not support our earlier conclusion that Tyr277 may function in cellulose
accommodation in proximity to the Zn2+ ion at the active center. The thesis discussed previously
that an equivalent tyrosine residue is not observed in available structures of other pEtN
transferases, nor was a tyrosine residue observed to participate in contact with the lipidbinding site in the structure of the full-length pEtN transferase EptA from Neisseria meningitidis
(NmEptAFL; PDD ID 5FGN). Instead, the equivalent residue to Tyr277 in NmEptAFL, Ser279, appears
to shape the lipid-binding pocket at the interface of the catalytic and membrane domains.
Consequently, we rationalized that this disparity in our data may indicate that the role of the
Tyr277 hydroxyl may instead be in stabilizing the local folding and interaction of the two EcBcsG
domains, and thus, allowing for EcBcsG to sample productive conformations during the catalytic
cycle. This hypothesis would account for the importance of Tyr277 to EcBcsG activity in vivo but
not to EcBcsGΔN in vitro. The remainder of our variant assay data was in good agreement with
the proposed active site, demonstrating strict dependence on the catalytic nucleophile/base
pair Ser278/His396 and coordination of the Zn2+ ion at the active center by Cys243, Glu442 and, to a
lesser extent, His443.
Molecular Determinants. To assess if the loss of activity observed for substitutions of the Zn2+binding residues was in fact due to the loss of Zn2+ in the EcBcsGΔN active site or was due to
structural changes in the enzyme, the metal chelating agent EDTA was supplied to EcBcsGΔN
prior to assay. Treatment with 1 mM EDTA was observed to reduce the specific esterase activity
of EcBcsGΔN to 10.6% of the untreated activity (Fig. 33). This significant loss of esterase activity

CHARACTERIZING BcsG

79

was in agreement with the large reduction in esterase activity observed for the replacement of
Cys243, Glu442 and His443. Surprisingly, however, the loss of transferase activity observed for
EDTA treatment was markedly less than that observed for single amino acid substitutions of the
Zn2+-binding residues, e.g. 43% residual activity of wild-type for EDTA treated, compared to
2.4%, 2.3% and 10.4% residual activity for replacements of Cys243, Glu442, and His443,
respectively. This data suggests that in addition to Zn2+ binding, Cys243, Glu442 and His443 may
also be catalytically important residues, particularly during the latter step of catalysis when
pEtN is transferred to cellulose.
Subsequently, the reducing agent DTT was introduced to EcBcsGΔN to assess the
importance of disulfide bond formation to enzymatic activity. An observed decrease in

Figure 33: Measured specific activities of EcBcsGΔN treated with the metal chelating agent EDTA and the
reducing agent DTT, both in the absence of cellopentaose (esterase) and in the presence (transferase).
wt = wild-type EcBcsGΔN.
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enzymatic activity, representing 31.9% of residual esterase activity was observed (Fig. 33). In
contrast, the measured residual transferase activity was 72.8% of wild-type. Large reductions in
the enzyme rate would be expected to agree with the functional complementation data, and
result in an inadequate level of pEtN, and thus, the fragile pellicle phenotype. However, the
limited reduction of the enzymatic rate in the presence of the reducing agent DTT is in apparent
disagreement with the fragile pellicle phenotype of the AR3110 ΔbcsG pBcsGΔN C290A C306A,
which displayed a pellicle phenotype not different from AR3110 ΔbcsG. This data is instead
rationalized by the highly specific requirements of exopolysaccharide modification for biofilm
formation. For example, the biofilm polysaccharide poly-β-(1,6)-N-acetyl-D-glucosamine,
sometimes abbreviated PNAG, requires only partial de-acetylation by the enzyme PgaB or its
orthologues for successful biofilm formation in various bacteria, including E. coli, S. aureus, and
Bortadella bronchiseptica21,34,106. PNAG found in biofilms has been observed to have
approximately 15-20% of the N-acetyl-D-glucosamine saccharide units to be deacetylated, with
either more or less extensive deacetylation causing disruption in biofilm formation, probably
due to the loss of a distributed cationic charge on the polymer33–35. Although a loss in EcBcsGΔN
activity of < 30% was measured in the presence of DTT, which could be considered trivial for the
biological function of some enzymes, the extent of pEtN modification to 50% of D-glucose
saccharide units has been observed of pEtN cellulose biofilms isolated from E. coli or S.
enterica32. As a result, even subtle reductions in the enzymatic rate, such as those observed
here, could still plausibly alter the degree of pEtN substitution so that is it not matched to the
rate of cellulose synthesis, disrupting the otherwise uniform charge and chemistry required for
biofilm formation.

CHARACTERIZING BcsG

81

5.6 Evidence for the EcBcsG catalytic mechanism
Identification of the covalent pEtN enzyme intermediate. A comprehensive catalytic

mechanism for any pEtN transferase family member has yet to be experimentally elucidated72.
Characterized enzymes belonging to the alkaline phosphatase superfamily tend to vary greatly
in the nature and number of metal ions in the active site, based on available structures of these
enzymes102. While the number of available structures in the pEtN transferase family remain
limited at present, it appears that at least one catalytic zinc ion is strictly conserved and is
indispensable for activity72,77. Several structures of MCR-1 are available, with one to four zinc
ions observed in the active site, although Hinchcliffe et al. demonstrated that the single strictly
conserved zinc ion is likely sufficient for at least part of the catalytic cycle72. Furthermore, pEtN
transferases are proposed to proceed by a ping-pong bisubstrate-biproduct (bi-bi) reaction
mechanism (Fig. 34), whereby the first step is pEtN transfer from a phospholipid to the enzyme
catalytic nucleophile, and the second step is nucleophilic attack of the covalent pEtN
intermediate by the acceptor substrate and turnover of the enzyme, although evidence for the
second step and its structural feasibility remain to be seen72. The structure of EcBcsGΔN
presented here demonstrates the presence of the single conserved catalytic zinc ion, and an
equivalent serine in place of the family consensus catalytic threonine, satisfying all structural
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Figure 34: Bisubstrate-biproduct reaction pathways. (A) The sequential bi-bi mechanism, in which both
substrates bind before the release of product. (B) The ping-pong bi-bi pathway, in which the release of
the first product and the formation of a covalent enzyme intermediate must occur before binding of the
second substrate.

criteria presented thus far for catalysis through the probable pEtN transferase ping pong bi-bi
mechanism. To further investigate the hypothesis that EcBcsG proceeds through such a ping
pong bi-bi reaction pathway, intact EcBcsGΔN was analyzed by LC- Q-TOF MS both before and
after substrate exposure to identify the covalent enzyme intermediate, if such an intermediate
exists (Fig. 35). The intact EcBcsGΔN mass spectra was composed of two predominant m/z
species corresponding to molecular ions of mass 45238.57 Da and 45318.54 Da. The 45238.57
Da species is not in agreement with the EcBcsGΔN sequence, with a theoretical molecular mass
of 45344.98 Da. Instead, the hypothetical molecular mass of a post-translationally modified and
mature EcBcsGΔN polypeptide, which accounts for the presence of a disulfide bond, formylation
of the N-terminal methionine residue, and loss of the C-terminal glutamic acid residue, is in
good agreement with the observed species, having a predicted molecular mass of 45242.84 Da.
The second species, with a molecular mass of 45318.54 Da, corresponds to a mass shift of
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Figure 35: LC- Q-ToF MS of intact EcBcsGΔN. The mass spectra of intact EcBcsGΔN (A) and of EcBcsGΔN
following substrate exposure (B) demonstrate that BcsGΔN proceeds through a covalent pEtN-enzyme
intermediate, and that recombinant EcBcsGΔN exists in solution as a mixed population of holo-EcBcsGΔN
and as a phosphorylated form.

+79.97 Da that is indicative of protein phosphorylation (Fig. 35; panel A). The observation of a
phosphorylated EcBcsGΔN species in solution is consistent with other pEtN transferase family
members, for which a phosphorylated species was observed in crystallo65,72,77. However, the
presence of a phosphorylated EcBcsGΔN, particularly with a comparatively high relative
abundance, was surprising as phosphorylated cellooligosaccharides were never detected as
enzymatic products by thin-layer chromatography or mass spectrometry, and suggested the
phosphorylated species is not catalytically relevant. In addition, EcBcsGΔN was purified in the
absence of phosphate or inorganic phosphorus, suggesting that the phosphorylation event
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must have occurred in the E. coli overexpression host, and may be an artefact of cytoplasmic
expression of the recombinant catalytic domain.
In an attempt to identify the site of phosphorylation, the structure of EcBcsGΔN was
refined de novo using an unbiased calculated electron density map obtained from initial
experimental phasing, with a spherical omit map of 10 Å centered around the catalytic zinc ion
to remove model bias that may have been introduced during initial refinement, and before the
detection of a phosphorylated EcBcsGΔN polypeptide in solution state. Surprisingly, no electron
density was calculated within 10 Å of the catalytic zinc that could be attributed to a
phosphorylated residue. The absence of the phosphorylated EcBcsGΔN species in the structure
presented here is reconciled by the spatial geometry of crystal packing, whereby the face of
EcBcsGΔN presenting the active site makes crystal contacts with a molecule in a neighbouring
asymmetric unit in both the P 212121 crystal form of EcBcsGΔN-Se and the P 21 crystal form of
EcBcsGΔN. Thus, phosphorylation of a residue in the active site would plausibly alter the surface
electrostatic potential of EcBcsGΔN, and may impede productive crystal packing, rationalizing
the incorporation of only holo- EcBcsGΔN into our structural model, despite the high relative
abundance of the phosphorylated form observed from intact protein LC- Q-TOF MS.
To then identify the presence of a covalent enzyme intermediate, if such a species
exists, LC- Q-TOF mass spectra of EcBcsGΔN were collected immediately following exposure to
the substrate analogue p-NPPE in large (300-fold) stoichiometric excess. In addition to the holoEcBcsGΔN (45238.57 Da) and phospho-EcBcsGΔN (45318.54 Da) species, the predominant
molecular ion had an observed molecular mass of 45362.31 Da, a mass shift of +123.74 Da
corresponding to the covalent addition of pEtN and representing the catalytically relevant
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covalent enzyme intermediate (Figure 35; panel B). Moreover, the detection of the covalent
enzyme intermediate was paralleled by a reduction in the relative intensity of the species
corresponding to the mass of holo-EcBcsGΔN, with no apparent change in the relative
abundance of the phosphorylated species. This observation was consistent with the hypothesis
that the phosphorylated species may not be catalytically relevant and provides evidence that
EcBcsGΔN proceeds through a covalent pEtN-enzyme intermediate, a requirement for the first
step of catalysis through a ping pong bi-bi reaction mechanism.
Determination of the EcBcsGΔN reaction order. Catalysis through a ping pong bi-bi reaction
mechanism mandates the interaction of cosubstrates to exclusive forms of the enzyme, that is,
the cosubstrate for the first step of the reaction mechanism, which generates the covalent
enzyme intermediate from the free enzyme, will not subsequently interact with the covalent
enzyme intermediate required for the second step regenerating the free enzyme, and vice
versa107. As a consequence, the rate of formation of the covalent enzyme intermediate will still
affect the net enzymatic rate, even when the concentration of the cosubstrate that regenerates
the free enzyme is saturating107. Conversely, because the rate of such a mechanism depends on
the concentration of both cosubstrates, increasing the concentration of one cosubstrate at a
fixed concentration of the other will result in an increase in the initial rate until the
concentration of the fixed cosubstrate becomes constraining107. These phenomena were first
described by Cleland, often termed Cleland’s rules107. The mechanism can thus be interpreted
from a Lineweaver-Burk reciprocal plot, where for enzymes following a ping-pong bi-bi
mechanism, plotting the double reciprocal of initial rate against varying concentration of one
cosubstrate at a fixed concentration of the other will result in linear relationships with unique
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intercepts but equal slopes, demonstrating the interaction of the two cosubstrates with
exclusive forms of the enzyme as is required for such a mechanism107. Alternately, a sequential
bi-bi reaction pathway, in which the cosubstrates interact with the same form of the enzyme at
some point in the catalytic cycle, would produce a double reciprocal plot of linear equations
with equal intercepts but unique slopes107. This is observed to be true in enzymes which
interact with both cosubstrates simultaneously, as the variation of one cosubstrate would fail
to influence the initial rate of the enzyme when the other cosusbtrate is saturating at any nonnegligible concentration of the other107.
To investigate the reaction order, and thus test the hypothesis that EcBcsGΔN follows a
ping pong bi-bi reaction pathway, the initial velocity was measured at cosubstrate
concentrations bracketing the Km for each (0.7, 1.4, 2.1 and 2.8 mM for p-NPPE and 0.5, 1, 2
and 2.5 mM for cellopentaose). Double reciprocal plots of initial velocity against (i) p-NPPE
concentration at a fixed cellopentaose concentration, and (ii) cellopentaose concentration at a
fixed p-NPPE concentration, were prepared and fit to linear models (Figure 36).
The resulting linear model data was analyzed with a regular one-way ANOVA,
determining that the slopes were not significantly different from each other (i: F(3,12) = 1.275,
p = 0.3273; ii: F(3,12) = 1.086, p = 0.3661). A Tukey’s test was conducted postanalysis for
pairwise comparison of each slope, and none were found to be significantly different from any
other (p > 0.3 for all cases). A subsequent ANCOVA was performed to test the null hypothesis
that the intercepts are equal, and the intercepts were found to be significantly different from
each other (F(3,11) = 188.1, p < 0.0001).
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The observation of double reciprocal initial velocity versus cosubstrate concentration
plots bearing parallel slopes with unique intercepts suggests that each cosubstrate used in the
EcBcsGΔN activity assay interacts with a different form of the enzyme. Hence, according to
Cleland’s rules, such a finding supports the hypothesis that EcBcsGΔN must proceed through a
ping-pong bi-bi reaction mechanism.

Figure 36. The reaction order of EcBcsGΔN by kinetic analysis. Lineweaver−Burk plots of initial rates of
reaction of 50 μM EcBcsGΔN in 50 mM NaCl, 50 mM HEPES pH 7.5, using varied concentrations of p-NPPE
(left) as the donor or cellopentaose (right) as the acceptor. Each data point represents 3 replicates.

Identification of Ser278 as the catalytic nucleophile. A conserved catalytic threonine is
proposed to serve the role of the catalytic nucleophile in the lipid A pEtN transferases,
evidenced by the observation of this conserved residue as phosphothreonine in the crystal
structures of several lipid A pEtN transferases65,72,77, and for its indispensability for catalytic
activity in vivo72,77. However, the structure of EcBcsGΔN presented here instead possessed the
equivalent Ser278 in place of the conserved threonine, and was never observed as
phosphoserine in crystallo, calling into question the identity of the EcBcsGΔN catalytic
nucleophile. To unambiguously identify the residue serving as the catalytic nucleophile,
EcBcsGΔN was briefly exposed to the substrate analogue p-NPPE (at 15 mM) to facilitate the
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formation of the covalent enzyme intermediate and was subsequently digested in sequencinggrade trypsin. The resulting tryptic peptide library was separated and analyzed by LC- Q-TOF MS

Figure 37: Identification of a phosphorylated EcBcsGΔN intermediate by LC- Q-ToF MS/MS.
Phosphorylated peptides were observed in the trypic peptide library of digested EcBcsGΔN, and
subsequent MS/MS localized this phosphorylation to the putative catalytic nucleophile Ser278.

to identify covalently pEtN modified peptides. Approximately 91% coverage was achieved in the
tryptic peptide library in complete agreement with the hypothetical EcBcsGΔN sequence.
Peptides containing the predicted catalytic nucleophile Ser278 were observed, along with similar
peptides containing a mass shift of +79.97 Da with high confidence (p < 0.0003), consistent with
the phosphorylated EcBcsGΔN species observed in the intact EcBcsGΔN mass spectra. However,
these peptides also contained other possible phosphorylation sites, including Ser273, Thr275,
Ser276, and Tyr277. To then localize the site of phosphorylation, peptides identified likely to be
phosphorylated were separated and analyzed by LC- Q-TOF MS/MS. The peptide fragment
spectra reveal that the +79.97 Da mass shift, corresponding to phosphorylation, was localized
to Ser278 for all phosphorylated EcBcsGΔN peptides from the trypsin digest with high confidence
(error ≤ 0.05 Da, FDR ≤ 1%; Figure 37 & Table 6).
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Table 6: Identification of phosphorylated peptides by LC- Q-ToF MS/MS1
#
Immonium
b
b-H2O
b-NH3
Seq
y
y-H2O
y-NH3
1
87.06
115.05
97.04
98.02
N
2
120.08
262.12
244.11
245.09
F
1521.67 1503.64 1504.65
3
87.06
376.16
358.15
359.14
N
1374.59 1356.60 1357.61
4
60.04
463.19
445.18
446.17
S
1260.58 1242.58 1243.54
5
44.04
534.21
516.23
517.20
A
1173.53 1155.50 1156.50
6
74.06
635.28
617.27
618.25
T
1102.49 1084.48 1085.47
7
60.04
722.30
704.30
705.31
S
1001.49
983.45
984.42
8
136.08
885.37
867.36
868.34
Y
914.40
896.40
897.39
9
140.01
1052.41 1034.36 1035.35
S (+79.97)
751.35
733.34
734.32
10
30.03
1109.41 1091.38 1092.39
G
584.35
566.34
567.32
11
70.07
1206.45 1188.44 1189.42
P
527.32
509.32
510.30
12
44.05
1277.48 1259.47 1260.46
A
430.27
412.27
413.25
13
44.05
1348.52 1330.51 1331.49
A
359.24
341.23
342.21
14
86.10
1461.61 1443.59 1444.58
I
288.20
270.19
271.18
15
129.11
R
175.12
157.06
158.09
1
All b and y ions corresponding to Figure 31 are coloured in blue and red, respectively. All ions were
detected with ≤ 0.05 Da error.
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#
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1

However, equivalent peptides bearing a mass shift of +123.74 Da, which would
correspond to the covalent pEtN intermediate, were not detected. The absence of pEtN-linked
peptides in the EcBcsGΔN tryptic peptide library was not surprising, as the covalent enzyme
intermediate would likely be short lived and unstable in the context of active enzyme in an
aqueous solvent, an outcome supported by the high apparent rate of esterase activity by
EcBcsGΔN described here (8.26 μM min-1). As such, the detection of the covalent enzyme
intermediate through tryptic digestion in solution would require the stability of the covalent
pEtN enzyme intermediate on the order of hours, which would likely not be possible under the
constraints of this experiment.
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6. Summary Conclusions
6.1 BcsG as a member of the phosphoethanolamine transferase family
The first objective in this thesis was a structural characterization of EcBcsG. The
experimental approach was appropriate and successful, revealing the three-dimensional
structure of the catalytically important C-terminal domain of EcBcsG to near-atomic resolution.
The structural model presented in this thesis respresents a significant contribution to the field
of microbial biofilms and the study of phosphoethanolamine transferases in several distinct
ways.
First, the data presented here demonstrates that EcBcsG, and presumably, orthologous
BcsG proteins, are both structurally and mechanistically similar to the polymyxin resistance
factors CjEptC, NmEptA, and MCR-1. This high degree of structural similarity of EcBcsG to the
polymyxin resistance factors is in stark contrast to its low amino acid sequence identity to these
proteins (22.4% CjEptC, 29.4% NmEptA, 25.0% MCR-1). Additionally, EcBcsG catalyzes the
transfer of pEtN to cellulose, while all three of the structural homologues discussed here
catalyze the transfer of pEtN to lipid A, a vastly different substrate. However, sequence
similarity and other in silico predictive tools estimate there are < 60 known or predicted pEtN
transferase family members identifiable from bacterial reference genomes, as reported by
Harper et al.63. Furthermore, phylogenetic analysis of these predicted pEtN transferases, first
reported by Harper et al. and updated here (Figure 13), suggest the grouping of these enzymes
into distinct subfamilies, which appear to cluster based on substrate specificity, supported by
biochemical characterization of a limited number of the analyzed sequences available in the
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literature. The low sequence identity of EcBcsG to all other known pEtN transferases not only
demonstrates the limited predictive ability of sequence analysis for this family, but also
indicates that the pEtN transferase family is likely far more expansive than predicted by Harper
et al. Furthermore, EcBcsG does not appear to cluster with any pEtN transferase family member
in the phylogenetic analysis, which may be indicative that EcBcsG, and related orthologues
could represent a novel subfamily of pEtN transferases for which no other members have been
described.
At present, the availability of structures of pEtN transferases is limited only to the
polymyxin resistance factors described here. While these enzymes are functionally distinct from
EcBcsG, it appears EcBcsG shares a highly conserved catalytic fold and mechanism, despite an
apparent sequence dissimilarity and phylogenetic distance. Although an understanding of the
various roles of pEtN transferases in bacteria are in their infancy, the discovery of BcsG as a
pEtN transferase suggests that the broader pEtN transferase family may share a highly
conserved overall fold and mechanism, despite the apparent variety of distinct reactions
catalyzed by them. Additionally, a link between the enzymes that confer resistance to
antimicrobial compounds and the enzymes that assemble the extracellular matrix
demonstrates a clear and unifying emergent theme for this enzyme family, serving to enhance
bacterial persistence and being shaped by the selective pressure of harsh, inhospitable, or
bactericidal environments.
Although it was not used in the structure solution or analysis of EcBcsG discussed here,
the structure and function of BcsG from Salmonella typhimirium (StBcsG; PDB id 5OLT) was
published during the timeline of this thesis by Sun et al. (2018)51. The structure of EcBcsG
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discussed here and of StBcsG, aligned using PyMOL with a r.m.s.d. of 0.531 Å across 2278
atoms, indicating a global similarity and suggesting these enzymes are truly structural
orthologues. Further site-directed mutagenesis studies of a limited set of residues reflected
particular phenotypes pointing to the importance of StBcsG to the pEtN cellulose biofilm51, in
support of the model proposed here. In conjunction, the role of the StBcsG N-terminal domain
in assembly of the mature bacterial cellulose synthase was confirmed51, which may be further
investigated in EcBcsG.

6.2 BcsG is a phosphoethanolamine transferase essential for extracellular matrix
architecture and assembly
The second objective of this thesis was a functional characterization of EcBcsG. The data
presented here provides, for the first time, an unambiguous demonstration of the true role of
BcsG in E. coli, both at the molecular level, and at the level of the microbial biofilm.
Furthermore, this thesis not only presented a model for the molecular and biological roles of
BcsG and phosphoethanolamine cellulose, but also demonstrated the molecular determinants
for BcsG activity.
The discovery of phosphoethanolamine cellulose by Thongsomboon et al.32 and its
importance in the role of infection by uropathogenic E. coli, reported by Hollenbeck et al.61
demonstrated that the role of bcsG in microbial cellulose biosynthesis and in microbial
pathogenesis and persistence was not trivial. This thesis demonstrates, for the first time, that
EcBcsG-directed pEtN cellulose is required for the structural integrity of the extracellular matrix
of E. coli. Furthermore, disruptions in the catalytic features of EcBcsG, first identified in this
research, result in a biofilm phenotype that is indistinguishable from a chromosomal deletion of

CHARACTERIZING BcsG

93

bcsG. This finding was coupled to an in vitro investigation, which demonstrated that the Cterminal catalytic domain of EcBcsG alone, in the absence of any other Bcs complex partner,
was sufficient to recapitulate the transfer of pEtN to various cellooligosaccharides, and that
disruptions in the catalytic features recapitulated the lack of activity seen in vivo.
However, several questions about BcsG still remain. In particular, it still remains to be
seen how the activity of BcsG is regulated to produce a polymer that is homogenously pEtNsubstituted with a precise stoichiometry of one pEtN to every-other saccharide as noted by
Thongsomboon et al. (2018)32. Furthermore, the interaction of BcsG with other Bcs complex
members is not well characterized, and the role of c-di-GMP and/or protein-protein
interactions in phosphoethanolamine cellulose biosynthesis are not yet clear. The specific roles
of bcsE and bcsF, encoded on a shared operon with bcsG, remain to be seen. Although
identified as a novel class of c-di-GMP receptor, BcsE was not necessary for the activity of
EcBcsGΔN in vitro. A bacterial two-hybrid study by Thongsomboon et al. showed that BcsE, BcsF
and BcsG appear to form stable interactions in vivo, and that BcsG appears to interact with the
BcsA/B synthase complex32. Sun et al. also demonstrated that the proper folding and
membrane insertion of the BcsG N-terminal domain is required for proteolytic stability of
BcsA51. However, no clear model of Bcs complex assembly is emergent from these
observations.
At present, the role of c-di-GMP signalling in the control of BcsG-directed pEtN cellulose
is unknown. Allosteric regulation of cellulose biosynthesis at the level of BcsA enzymatic activity
is known to be dependent upon c-di-GMP binding to the PilZ domain of BcsA53, and so it is
tempting to speculate that BcsE might serve an analogous role in the allosteric regulation of
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BcsG activity. One other distinct mechanism of exopolysaccharide synthase complex regulation
has been described in support of this theory108. The biosynthesis of poly-β-1,6-Nacetylglucoasmine (PNAG), an exopolysaccharide produced by E. coli and other bacteria, is
carried out by both PgaC and PgaD, the two inner membrane components of the PNAG
synthesis machinery responsible for glycosyltransferase activity109. Binding of c-di-GMP to both
PgaC and PgaD stabilizes their interaction and promotes enzyme activity resulting in PNAG
synthesis, and proteolytic stability of PgaD in vivo is c-di-GMP dependent108.
Such a two-level mechanism of regulation of the pEtN cellulose synthase is certainly
possible under the current model for its function and protein-protein interaction. Already, the
proteolytic stability of BcsA appears to be dependent upon interaction with the BcsG Nterminal domain51, and its activity further depends on the binding of c-di-GMP to the BcsA PilZ
domain53. Whether the proteolytic stability or activity of BcsA and/or BcsG depends upon ligand
binding to the BcsE GIL domain remains to be seen, although such a mechanism seems
plausible given the apparent structural and functional homology among Gram-negative
synthase-dependent exopolysaccharide biosynthetic machines23.
6.3 Mechanism of action of pEtN transferases
The third objective of this thesis was an investigation of the catalytic mechanism of
EcBcsG. The experimental methods and data described here were successful in demonstrating a
limited set of the requirements for catalysis through a ping-pong bi-bi reaction mechanism. The
results presented here support the hypothesis that pEtN transferases proceed by this
conserved mechanism, although the molecular details of the complete catalytic cycle still have
yet to be demonstrated.
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While the individual substrates for which known and predicted pEtN transferases
catalyze transfer of pEtN vary greatly, it is generally believed that the physiological donor of
pEtN in all cases is the membrane phospholipid phosphatidylethanolamine, enriched in the
inner membrane of Gram-negative bacteria, and supported by experimental evidence from
Thoingsomboon et al.32. Such a model accounts for the presence of an N-terminal
transmembrane domain known or predicted to localize to the inner membrane for all pEtN
transferases63. This model then supports catalysis through a ping-pong bisubstrate-biproduct
reaction pathway, in which the catalytic domain cleaves the pEtN group with a catalytic
nucleophile and liberating diacylglyerol as the first enzymatic product, and subsequently
presents the pEtN to the acceptor cosubstrate, at which point it is cleaved and covalently
bonded to the second enzymatic product72. A ping-pong mechanism of action would then
mandate this catalytic cycle be completed in two discrete steps, where binding of the first and
second cosubstrates occur only to the holoenzyme and the covalent enzyme intermediate,
respectively. However, this mechanism remains highly speculative, and the only experimental
evidence available to support such a mechanism was reported by Hinchliffe et al.72 that density
functional theory calculations on available structures of MCR-1 indicate that at least the first
step of this mechanism is energetically feasible.
This thesis then provides, for the first time, direct and unambiguous experimental
evidence for catalysis through a ping-pong bi-bi mechanism of action. The existence of a
covalent pEtN-BcsG enzyme intermediate was identified and is the first enzyme in the pEtN
transferase family known to possess such a covalent intermediate. Furthermore, Cleland’s
rules107 were applied, and demonstrated that the apparent kinetic behaviour of BcsG support a
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ping-pong bi-bi mechanism. Based on the existence of a covalent enzyme-intermediate, and the
exclusion of a sequential bi-bi mechanism based on kinetic behaviour, the data presented here
confirm that BcsG, and likely the known members of the pEtN transferase family described
here, proceed through a ping-pong bi-bi reaction mechanism.
However, several mechanistic details remain to be seen, and there is limited evidence
for the role of each essential amino acid in the catalytic cycle. For example, the results
demonstrate that H396 and Y277 are essential for EcBcsG activity both in vivo and in vitro.
However, the role of these amino acids cannot be inferred from the structural model of EcBcsG.
Further efforts to experimentally resolve a BcsG-substrate complex would be required for a
complete understanding of how these residues participate in the catalytic cycle78. Furthermore,
the structure and in vitro activity were demonstrated using a recombinant construct of BcsG
containing a defined truncation of the N-terminal transmembrane domain. The structure of the
full-length NmEptA pEtN transferase, including the N-terminal transmembrane domain, was
also reported by Anandan et al (PDB id 5FGN), and suggested how conformational change may
influence lipid-binding, and play an important catalytic function throughout the catalytic cycle.
Instead, our experimental approach focused on an artificial pEtN donor not linked to a lipid.
Accordingly, the catalytic importance of a lipid-binding site in the N-terminal domain and its
interactions with the membrane and/or other membrane proteins was not investigated. Finally,
while the results here establish a plausible, experimentally-supported mechanism for the
interaction of EcBcsG with the pEtN donor during the first step of the proposed catalytic cycle,
the mechanistic basis for the binding of cellulose and subsequent transfer of pEtN during the
second step of the catalytic cycle remain completely unknown. A complete understanding of
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the molecular determinants of binding to both cosubstrates is required before a complete
catalytic mechanism can be confidently proposed.

6.4 BcsG as a therapeutic target for microbial infections
The success of this thesis in addressing all three key objectives outlined within has
provided significant advancement of the contemporary understanding of microbial
phosphoethanolamine cellulose biosynthesis. Beyond this, it is critically important to
contextualize the research findings of this thesis and highlight the potential impacts and
significance that this new knowledge will provide to collective humankind.
Biofilms have been estimated to be implicated in >60% of infections observed in the
clinic3, making them an important factor in public health and infectious bacterial disease.
Additionally, biofilm-associated genes in pathogens are considered virulence factors12,
contributing to antimicrobial resistance. The importance of pEtN cellulose to uropathogenic E.
coli during the course of urogenital tract infection further highlights the link between biofilm
formation and infection20,61. Antimicrobial resistant infections are predicted to be the leading
cause of death worldwide by 2050, surpassing annual mortality by cancer and cardiovascular
disease79. Beyond infection, the presence of biofilms on fresh produce or other food items can
also cause significant economic losses in addition to health concerns14. For these reasons, the
development of new therapeutic strategies, biocontrol agents, or new clinical drugs is essential
to combat the rising threat of recalcitrant bacterial infection and persistence.
The structure, activity, and mechanism of BcsG that is explored in this thesis all provide
promising evidence that BcsG would be a suitable therapeutic target to attenuate the virulence
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and persistence of bacteria who produce pEtN cellulose. As discussed above, the work
presented here demonstrates that BcsG alone is essential for the architecture and assembly of
the biofilm matrix in E. coli. Accordingly, the development of a small-molecule inhibitor, or
other method, to abrogate BcsG activity would represent an effective strategy for the
treatment of drug-resistant or otherwise persistent colonization by bacteria. Furthermore, the
results in this thesis show that obstruction of pEtN cellulose is not cytotoxic to cells, and such a
strategy to inhibit the biofilm of bacteria likely would not be met with strong selective pressure
for resistance. This is in contrast to the emerging resistance of bacteria to conventional
antimicrobial drugs, which has rapidly become a global threat to public health79. However, pEtN
and phosphatidylethanolamine also contribute to eukaryotic cell membranes, and so the genes
responsible for the biosynthesis and turnover of pEtN and pEtN-associated lipids may be
conditionally essential to humans, making pEtN transferases a challenging molecular target. For
example, the PHOSPHO1 gene, encoding a phosphocholine/phosphoethanolamine phosphatase
is important for liberating inorganic phosphate in mineralizing cells110, and so disruption of the
cellular pEtN pool may have deleterious effects on bone growth and development in humans
and animals. Furthermore, because of the apparently conserved structure and mechanism of
pEtN transferases explored here, such a strategy to abrogate BcsG-directed pEtN cellulose may
also inhibit the activity of other antimicrobial drug resistance enzymes, limiting the potential for
resistance for polymyxins - at least by the mechanisms described here.
The requirements for pEtN transferase activity appear to be conserved, as the results
herein recapitulate those of Hinchcliffe et al. for MCR-172. Zinc-binding, disulfide bond
formation, and the correct orientation and chemistry of amino acids involved in contacts with

CHARACTERIZING BcsG

99

either cosubstrate are indispensable for the activity of BcsG both in vivo and in vitro. This
knowledge of the essential catalytic features of BcsG, and the resolution of its overall structure,
represent significant advances in contemporary knowledge of bacterial cellulose biosynthesis
and enable future efforts for structurally informed inhibitor design.
Although only just recently discovered in E. coli and S. enterica at the time of writing,
pEtN cellulose represents a naturally produced, chemically modified form of cellulose which
may prove useful as a biomaterial. The research presented in this thesis, in addition to the
findings contributed by Hollenbeck et al.61 and Thongsomboon et al.32, demonstrate that pEtN
cellulose has unique properties from unmodified microbial cellulose that contribute to the
rigidity of the extracellular matrix. Although the mechanism for this apparent rigidity remains to
be seen, Hollenbeck et al. demonstrated that pEtN cellulose appears to serve in maintaining the
association of curli fimbriae to the bacterial cell surface61

7. Integrative Nature of This Research
Biofilms are one of the most successful and widely distributed forms of life on Earth and
are the predominant form of life for bacteria and archaea1,111. Biofilms are complex, selfassembling extracellular matrices with large diversity in the biosynthesis of the materials that
constitute them, the properties they confer to their constituents, the microorganisms that
produce them, and the habitats they colonize. Accordingly, a complete understanding of
biofilms requires a comprehensive model that accounts for the biological processes that govern
them, ranging from the molecular level to the level of microbial ecology. The research
described in this thesis concerns, primarily, the molecular mechanisms underlying the
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biosynthesis of the exopolysaccharide from the model organism E. coli. In order to address the
complex phenomenon of biofilms that span many levels of the hierarchy of biological science,
the experimental approach of this thesis included a corresponding investigation of the biofilm
at many different levels. Beginning at the level of small molecules, this research describes the
enzymatic product of BcsG, pEtN cellulose, as well as the individual molecular determinants for
BcsG catalysis. The thesis also addresses this phenomenon at the enzyme level, demonstrating
the overall fold and structure of the BcsG enzyme. Furthermore, this thesis addresses the
consequences of BcsG-mediated pEtN cellulose on the properties of the biofilm at the cellular
and the population level using the pellicle phenotype experiment. This experimental approach
that encompasses many levels of biology is exemplary of integrative research.
Beyond the study of biological processes, this thesis also describes multidisciplinary
research spanning the disciplines of the life sciences. For example, synthetic and analytical
chemistry were paramount to the experimental approaches used here to demonstrate the
activity of EcBcsG in vitro. The near-atomic resolution structure of EcBcsG described here was
accomplished by X-ray crystallography, a technique centered around modern innovations in the
fields of physics, chemistry and mathematics. Finally, computational biology and sequence
analysis were important experimental techniques necessary to contextualize the structure of
EcBcsG and understand its evolutionary relationship to other known sequences and structures.
The research described in this thesis involved many multidisciplinary approaches to answer
important and meaningful questions about biological processes that could not be addressed
with the conventional tools for the study of biology alone.
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Finally, the results presented here are the result of a largely collaborative effort, both
within the institution and outside. The strains used in this study were the result of a
collaboration with Thongsomboon et al., the chemical synthesis of p-NPPE was possible
through a collaboration with Dr. Ken Maly in the Department of Chemistry & Biochemistry at
Wilfrid Laurier University, and the mass spectrometry experiments were performed with the
expert supervision of Dr. Armen Charchoglyan and Dr. Dyanne Brewer of the Advanced Analysis
Facility, University of Guelph.
Through the study of biology at many levels, through many diverse and multidisciplinary
techniques, and through many collaborations, the research presented here was made possible.
For these reasons, the very nature of this thesis is Integrative Biology.

8. Summary and significance
Biofilms have been estimated to be implicated in >60% of infections observed in the clinic3,
making them an important factor in public health and infectious bacterial disease. Additionally,
biofilm-associated genes in pathogens are considered virulence factors12, contributing to
antimicrobial resistance. Antimicrobial resistant infections are predicted to be the leading cause
of death worldwide by 2050, surpassing annual mortality by cancer and cardiovascular
disease79. The presence of biofilms on fresh produce or on other foodstuff can also cause
significant economic losses in addition to health concerns14. The structural and functional
model of the cellulose modifying complex offers opportunities in structure-based drug
discovery and other efforts in inhibiting microbial biofilms and limiting the resilience of biofilm-
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forming pathogens. Additionally, the new understanding of BcsG-directed
phosphoethanolamine cellulose production provided by this thesis may enable biosynthetic
engineering of new cellulosic materials or confer the advantages of phosphoethanolamine
cellulose in new organisms.
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Appendix 1
Synthesis of p-nitrophenylphosphorylethanolamine. Reagents and starting materials were purchased
from Millipore-Sigma and used as received. Anhydrous and oxygen-free solvents were dispensed from a
custom-built solvent purification system which used purification columns packed with activated alumina
and supported copper catalyst (Glasscontour, Irvine, CA) and maintained under argon. Melting points
were determined on a Mel-Temp® Electrothermal melting point apparatus and are uncorrected. High
resolution mass spectra were recorded at the Centre Régional de Spectrométrie de Masse à l’Université
de Montréal using an Agilent LC-MSD TOF spectrometer in the ionisation mode indicated. Elemental
analysis was conducted by Midwest Microanalysis. NMR spectra were recorded on an Agilent
Technologies 400 MHz (1H, 13C, 19F) or 300 MHz (31P) spectrometer using deuterated solvents purchased
from CIL Int. Chemical or Millipore-Sigma; shifts are reported (δ-scale) using the residual solvent peak as
reference. In the case of 19F and 32P NMR no reference was used.

(i)

pyridin-1-ium 2-((tert-butoxycarbonyl)amino)ethyl (4-nitrophenyl) phosphate

To a 100 mL 2-neck round-bottomed flask, equipped with N2 inlet and magnetic stir bar, was added pnitrophenyl phosphodichloridate (3.64 g, 14.2 mmol, 2 eq), dry THF (35 mL), and pyridine (2.3 mL, 28.4
mmol, 4 eq), and the resulting clear colourless solution was cooled to 0 °C (ice-water bath). A solution of
N-Boc-ethanolamine (1.10 mL, 7.11 mmol, 1 eq) in dry THF (20 mL) was added dropwise via syringe to
the cold solution with formation of a white precipitate, and the mixture stirred at room temperature
overnight. A solution of pyridine (2.3 mL, 28.4 mmol, 4 eq) in H2O (10 mL) was then added and the clear
solution stirred 10 minutes further. The volatiles were removed via rotary evaporation yielding a yellow
oil which was dissolved in H2O (50 mL). The aqueous layer was washed with EtOAc (3 × 50 mL), extracted
with CH2Cl2 (3 × 50 mL), and the CH2Cl2 layer washed with H2O (1 × 25 mL), dried over Na2SO4, and
concentrated via rotary evaporation yielding a clear oil which solidified upon standing to give a white
solid (1.43 g, 3.24 mmol, 46%). mp (EtOAc) = 98.5−99.5 °C; 1H NMR (400 MHz, DMSO-d6) δ: 8.77 (dt, J =
4.9, 1.6 Hz, 2H), 8.26 (tt, J = 7.8, 1.7 Hz, 1H), 8.19 (d, J = 9.2 Hz, 2H), 7.79 (dd, J = 7.8, 6.2 Hz, 2H), 7.40 (d,
J = 9.2 Hz, 2H), 6.91 (br s, 1H), 3.85 (dt, J = 7.5, 6.0 Hz, 2H), 3.11 (q, J = 5.9 Hz, 2H), 1.33 (s, 9H); 13C NMR
(100 MHz, DMSO-d6) δ: 158.47 (d, J = 6.1 Hz), 155.91, 145. 67, 142.97, 142.38, 126.27, 125.83, 120.78 (d,
J = 5.4 Hz), 78.07, 65.00 (d, J = 6.3 Hz), 40.95 (d, J = 6.3 Hz), 28.57; 32P NMR (162 MHz, DMSO-d6) δ: −6.92
(s); HRMS (ESI−): Calc. for C13H18N2O8P [M−]: 361.08063 Found: 361.08074.

CHARACTERIZING BcsG
(ii)

112

2-aminoethyl (4-nitrophenyl) hydrogen phosphate

To a solution of N-BOC-ethanolamine pyridinium salt (850 mg, 1.92 mmol) in CH2Cl2 (10 mL) was added
trifluoroacetic acid (0.8 mL) and allowed to stand 1.5 h. After this time the volatiles were removed via
rotary evaporation (bath temperature ≈ 50 °C) yielding a clear, colorless oil. White crystals of the
trifluoroacetate salt were obtained from EtOAc (7 mL) upon cooling to −15 °C overnight and collected
via suction filtration, washing with ether (400 mg, 1.53 mmol, 79%). 1H NMR (400 MHz, D2O) δ: 8.21 (d, J
= 8.8 Hz, 2H), 7.29 (d, J = 9.0 Hz, 2H), 4.19 (q, J = 5.7 Hz, 2H), 3.25 (t, J = 4.5 Hz, 2H); 13C NMR (100 MHz,
D2O) δ: 157.02 (d, JC−P = 6.3 Hz), 143.56, 125.81, 120.31 (d, J = 5.0 Hz), 62.54 (d, J = 5.4 Hz), 39.79 (d, J =
8.2 Hz); 32P NMR (121 MHz, DMSO-d6) δ: −6.71; Found: C, 36.48; H, 4.22; N, 10.56; P, 11.61. C8H11N2O6P
requires C, 36.65; H, 4.23; N, 10.69; P, 11.81.

Appendix Figure A1: Annotated 1H NMR spectra for the para-nitrophenyl-N-BOCphosphorylethanolamine pyridinium salt synthetic intermediate.
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Appendix Figure A2: Annotated 13C NMR spectra for the para-nitrophenyl-N-BOCphosphorylethanolamine pyridinium salt synthetic intermediate.
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Appendix Figure A3: Annotated 31P NMR spectra for the para-nitrophenyl-N-BOCphosphorylethanolamine pyridinium salt synthetic intermediate.
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Appendix Figure A4: Annotated 1H NMR spectra for the para-nitrophenyl phosphorylethanolamine
trifluoroacetate salt. Asterisks denote resident ethyl acetate sovlent detected that could not be assigned
to the synthetic product.
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Appendix Figure A5: Annotated 13C NMR spectra for the para-nitrophenyl phosphorylethanolamine
trifluoroacetate salt.
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Appendix Figure A6: Annotated 31P NMR spectra for the para-nitrophenyl phosphorylethanolamine
trifluoroacetate salt.
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Appendix Figure A7: Annotated 19F NMR spectra for the para-nitrophenyl phosphorylethanolamine
trifluoroacetate salt.

CHARACTERIZING BcsG

120

EcBcsG
CjEptC
NmEptA
MCR-1

1
1
1
1

MT Q - - - - F T Q - - - - N T AMP S S L WQ YWRG L SGWN F Y F L V K FG L L WAG Y L - - - - - - N FH P L - - - - - L N L V F A A F L L MP
- - M L R L T WFQ F T F FN S L M- - - - - - - - I V L L N FN L F Y F V Y E K - - - - - N - T QN WL I T F V F I V A Y F A L VH V I C S L L F I - M I K PN - - L R P K L G S SA L I A F L S L Y S S L V L N Y A F F A K V V E L H P FN G T G AD I F L Y T - MP V V L F F L SN F V F - H V I A L MMQH T SVWY R R SV SP F V L V A SV A V F L T A T AN L T F FD K I SQ T Y P I AD N L - - G F V L T - I A V V L FG AM L L I T T L L S SY -

EcBcsG
CjEptC
NmEptA
MCR-1

58
60
71
73

EcBcsG
CjEptC
NmEptA
MCR-1

131
130
142
144

F - - L SQW- - - - - - I
K I D Y YG S F K SH I K I
K V K Y R VWY K E L L T K VD Y P T WG KG L MR -

EcBcsG
CjEptC
NmEptA
MCR-1

170
205
216
219

T V T T T GGN A A A T V A A T GG A P V VGD MP AQ T A P P T T AN L N AWL N N F YN A E A K R K ST F P S S L P AD AQ P F E L L V I
T - - - - - I AN D A Y R EN N H T K K L L V L V VG E T A R A AN Y S L GG Y T KN D T N F Y T K - KD N - - - - - - - - - - - - - - - - - - - Q L D MA V VQN R P AG S L R R F V V L V VG E T T R A AN WG L N G Y SRQ T T P L L A A RGD E - - - - - - - - - - - - - - - - T I YH A KD A VQ A T K PD MR K P R L V V F V VG E T A R AD H V S FN G Y E RD T F PQ L A K - I D G - - - - - - - - - - - - - - - - -

EcBcsG
CjEptC
NmEptA
MCR-1

246
253
267
272

SWSD I
- - - - - - - - - - - - -

L P R Y S L H R L RH W I A L P I G F A L F - WH D T WL PG P E S I M SQ - G SQ V AG F ST D Y L I
- - K F F T K F F - S I L F I I S S F L SV Y F I S F YG V L I D SD MMQN V VQ T D I K E V KD L - - P F VH K V L - I P L I L V I SA A V SYQ E I F FN I Y FN K SM L N N V L Q T T A A E SA R L - - R Y V L K P V - L I L L L I MG A V T SY F T D T YG T V YD T T M L QN A L Q T D Q A E T KD L -

57
59
70
72

D L V T R F I N WQM I - G A I F V L L V AWL
- LN L K L I L FV V L - A L L L V FY V V K V
- I T PG Y V L W I V C L G V L P A L A Y I A V
- L N A A F I MR I I G L G V L P S L L V A F V

130
129
141
143

R I T V F V V A I L L WL N V L - - - - - - - - - - - - - - - - - - T L AG P S F S L WP AGQ P T - - - - - - - - - - - T
K I I N I I SG L I V V C A V L I P L SK T F L P F F RN YN E I RMYN T P F YQ I Y A V Y R Y - Y V R F V K A K P E F K
R L V L A A V S F L C A L G I AM L Q YQD Y A S F F RN N K SV T H L I V P SN F I - G AG V SK Y KD WK R SN I P Y T
R L G L I V A S L A L I L L P V V A F S SH Y A S F F R VH K P L R SY VN P I MP I Y SVG K L A S I E Y K K A SA P KD

169
204
215
218

CSL
- - - - - - -

245
252
266
271

E A AG L M SH P L WSH FD I E F KN F - - - N SA T SY S
SG P A A I R L L R A SCGQ T SH T N L YQ P AN N D C Y L FD N L SK L G F T
- - - - - - - - - - - - - - V V F FD N F S SCG T A T A V S L P CM F S I SK R EN Y S- - - - - - - - S SE FQ EN AMD V L Y K T G VD
- - - - - - - - - - - - - - I VN F PQ V R SCG T ST
T AH S L P CM F ST FD R T D YD E - - - - - - I K A EH QD N L L D I VQ R AG V E
- - - - - - - - - - - - - - V T N F SN V T SCG T ST
T A Y SV P CM F SY L G AD E YD V - - - - - - D T A K YQ EN V L D T L D R L G V S

318
301
317
322

EcBcsG
CjEptC
NmEptA
MCR-1

319 QH L MMGH N GQ FGG F L K E V R EN GGMQ SE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - L MD Q T N L P V I L L G FD G S
302 A VWFD N N SGG C KG V CD R L A Y KQ K L S SD - - - - - - - - - - - - - - - - L D EN L L A P F K E K - L N H L SD QN I I V L H L QG SH
HGP
318 V T WL EN D S- G C KG V CG K V PN T D V T S L N L P - - - E Y C - - - RN G E C L D N I L L T K FD E V - L N KN D KD A V L I L H T I G SH
HGP
323 I L WRD N N S- D SKG VMD K L P K AQ F AD Y K SA T N N A I CN T N P YN E C RD VGM L VG L D D F V A AN N G KD M L I M L H QMGN H G P

362
360
385
397

EcBcsG
CjEptC
NmEptA
MCR-1

363
361
386
398

P V YD D T A V L N RWL D V T E KD KN SR SA T F YN T L P L H D GN H Y PG V SK T AD - - - Y K A - - - R AQ K F FD E L D A F F T E L E K SG
T Y Y K R Y P - - - - - - - - - - - - - - - - - SE F K K F T P T CD T N E L SK CD SE A L I N T YD N T L L Y T D Y L L SE I I K L L - K EQ K - S
T Y Y E R Y T - - - - - - - - - - - - - - - - - E A E R K F T P T CD T N E I N K C T R A T L VN T YD N T V L Y VD Q F I D K V I R K L - EN RD - D
A Y F K R YD - - - - - - - - - - - - - - - - - E K F A K F T P V C EGN E L A K C EH Q S L I N A YD N A L L A T D D F I AQ S I QWL - Q T H SN A

432
417
442
455

EcBcsG
CjEptC
NmEptA
MCR-1

433
418
443
456

R K VMV V V V P EH GG A L KGD RMQ V SG L RD I P SP S I T D V P VG V K F FGMK A PH QG A P I V I
Y E S S L F Y L SD
D H G E S L G EN G I Y L H GMP Y A I A P SYQ T H I P A I FWSN D KN L MN L - A K E L E SV VH Y V SD
D H G E S L G EN GMY L H A A P Y A I A P SGQ T H I PMVMWF SK A F RQH G - G I D YD V SM L Y V SD
D H G E S L G EN G V Y L H GMPN A F A P K EQ R SV P A F FWT D KQ T G I T P - - - - -

508
475
507
511

EcBcsG
CjEptC
NmEptA
MCR-1

509 I F T ED N VD WK K L T SG L PQ T A P V SEN SN A V V I
476 K L SQD N L - - - - - F ST L L G Y FD V K T S- - - V - 508 E Y SH D H Y - - - - - F ST V L G L MD I SN S- - - Q - 512 V L T H D A I - - - - - T P T L L K L FD V T AD - - - K - -

Q YQD K P Y V R L N GGD WV P Y PQ
- Y E - P E Y - D L L N P K L K AN P T Y R - K EM- D I L A A C R R P R - V KD - R T A - F I R - - - - - - - - -

NI
- - - -

EQ P S S F L A I SD L V V R V L D G K
- - - - - Y - - - - - - - - - - - KG L
- - - - - FQ C L K - - - - Q K A A EN
- - - - - - - - - - - - - - - MA T D T

559
512
544
541

Appendix Figure A8: Complete sequence alignment of EcBcsG, CjEptC, NmEptA, and MCR-1 using ClustalOmega.
Important active site residues are highlighted in red and alignment gaps are indicated with a hyphen.

